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CHAPTER I
REVIEW OF LITERATURE
Childhood Depression
The prevalence of major depression in children ranges from 0.4% to 2.5%
(Cicchetti & Toth, 1998) with similar rates for boys and girls (see Birmaher et al., 1996).
Childhood depression is characterized by a range of behavioral, cognitive and
physiological symptoms. These symptoms include irritability, diminished interest or
pleasure in activities, failure to make expected weight gains, sleeping problems, loss of
energy and fatigue, feelings of worthlessness, diminished ability to concentrate, social
withdrawal (DSM-IV-TR, APA, 2000), somatic complaints (Birmaher et al., 1996), low
self-esteem, cognitive distortions (McCauley, Mitchell, Burke, & Moss, 1988), negative
thinking (Mash & Wolfe, 2007), negative, unrealistic, and unreasonable self-evaluations
(Kendall, Stark, & Adam, 1990; Stark, Swearer, Kurowski, Sommer, & Bowen, 1996),
and adjustment problems (Levendosky, Okun, & Parkert, 1995). Depressive episodes
experienced by children can be of a long duration and children who overcome their initial
depressive episode are at high risk for experiencing later episodes of depression and
impairments in other domains of their life (Mash & Wolfe, 2007).
In addition to those meeting DSM criteria for major depression there are a

substantial number of children with significant, yet sub-threshold symptoms that
experience functional impairment and are at risk for worsening symptoms. Moreover,
1
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depressive disorders may be under-recognized in children due to their inability to verbally
express feelings, the presence of accompanying psychiatric symptoms which can make
recognition of depressive symptoms difficult, and the fact that unless a child is especially
irritable, aggressive, or exhibits marked social withdrawal, depressive symptoms might
not be noticed by parents or teachers (Sabatino, Webster, & Vance, 2001).
Cognitive Behavioral Treatment (CBT) for Childhood Depression
Cognitive behavioral treatment (CBT) is the best-evaluated psychosocial
treatment (Harrington, Whittaker, & Shoebridge, 1998; Weersing & Weisz, 2002; Weisz,
Hawley, & Jensen-Doss, 2004) and has been the most frequently investigated for
depression in young people (Birmaher et al., 1996; Feehan & Vostanis, 1996; Kaslow &
Thompson, 1998; Kazdin & Weisz, 1998; Weisz et al., 2004; Weisz, Jensen Doss, &
Hawley, 2005). There are 10 controlled studies of CBT interventions with school age
children who presented with elevated depressive symptoms (Asarnow, Scott, & Mintz,
2002; Butler, Miezitis, Friedman, & Cole, 1980; De Cuyper, Timbremont, Braet, De
Backer, & Wullaert, 2004; Eckshtain & Gaynor, 2007a; Kahn, Kehle, Jenson, & Clark,
1990; Liddle and Spence, 1990; Stark, Reynolds, & Kaslow, 1987; Vostanis, Feehan,
Grattan, & Bickerton, 1996; Weisz, Thurber, Sweeney, Proffitt, & LeGagnoux, 1997;
Wood, Harrington, & Moore, 1996). In general, the studies support the potential efficacy
of CBT, making it the psychosocial treatment with the greatest base of evidence to
support its use in treating children with depressive symptoms. As Chorpita et al. (2002)
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summarized in a recent review of the literature, "Of the available psychosocial treatments
reviewed, CBT appeared to be the treatment of choice" (p. 175).
Six of the 10 studies of CBT have used school-based samples with treatment
delivered in a group format (Feehan & Vostanis, 1996). There are advantages to group
interventions, such as increasing access to and cost-effectiveness of services. Some
potential limitations also warrant consideration, such as ensuring individualized
application of skills within the groups and involving caregivers in the treatment. These
latter considerations are more easily accomplished when children receive individual
treatment. Thus, there appears to be a give-and-take relationship between various
treatment format. As for service delivery location, two of the explicitly stated goals
emerging from the Report of the Surgeon General's Conference on Child Mental Health
(U.S. Public Health Service, 2000) were to (a) "continue to develop, disseminate, and
implement scientifically-proven prevention and treatment services in the field of
children's mental health" (USPHS, 2000, p. 5) and to (b) "increase access to and
coordination of quality mental healthcare services" (USPHS, 2000, p. 7). To accomplish
these goals, the report recommended making services available to youth in places where
they congregate, such as schools, and evaluating the utility of services delivered in these
real-world settings to determine their effectiveness and increase the connection between
research and clinical practice (see also Tolan & Dodge, 2005).
Based on these recommendations, the goal of the present study was to offer free
individual CBT, provided at school. This approach allowed children who might not have
been able to receive specialized services at a clinical setting due to financial,
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transportation, or other familial considerations to access services. In addition, conducting
treatment onsite appeared to optimize referrals and access to treatment because school
staff (including teachers, school psychologists, counselors, and social workers) are
usually among the first to identify problems (Connor-Smith & Weisz, 2003; Reynolds &
Stark, 1987), may even be better than parents in identifying internalizing problems in
children (Mesman & Koot, 2000), and thus can facilitate and support appropriate referrals
to the treatment study (Connor-Smith & Weisz, 2003; Reynolds & Stark, 1987). In
addition, providing treatment for depression at school has other benefits, including the
fact that some depressive symptoms, like social withdrawal and academic difficulties, can
be best observed at school (Burns & Hickie, 2002).
In one of the largest CBT randomized clinical trials with children, Weisz et al.
(1997; see also Weisz, Southam-Gerow, Gordis, & Connor-Smith, 2003) compared CBT,
using the Primary-Secondary Control Enhancement Training (PASCET) manual (Weisz
et al., 1997), with a no-treatment control condition in elementary school students. The 16
children who received PASCET, provided in groups and at school, had significantly
greater reductions in depressive symptoms compared to the 32 in the wait-list control
condition. The PASCET manual (Weisz, Moore, & Southam-Gerow, 1999) was used in
the current study in its revised version adjusted to be administered in 16,45-minute,
sessions. However, Weisz et al. (1997), like many studies, included only children who
met the criteria for depressive disorders targeted in the study. This may create a situation
that is different from clinical settings, where clinicians often see children with multiple
difficulties and disorders (Connor-Smith & Weisz, 2003). Thus, in the current study
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significant depressive symptoms were required for inclusion but exclusionary criteria
were as unrestrictive as possible to allow for better generalization of findings.
Despite the empirical support CBT has as a treatment for depressed youth, a
recent meta-analysis (Weisz, McCarty, & Valeri, 2006) of the effects of psychotherapy
for depressed children and adolescents had somewhat pessimistic conclusions about the
current state of treatment. They found that treatments produce significant effects, but that
the effects are modest in strength, breadth, and durability and that depression treatments
do not surpass (but instead may lag significantly behind) treatments for other youth
conditions. Following these findings, two of their recommendations were to increase the
dose of treatment (with the average dose being 13 hours) and to increase the potency of
treatments by adding components to create more multi-component packages and by
encouraging the use of new methods. One of the components that can be added to the
treatment of depressed youth is greater inclusion of caregivers.
The Family and the Child with Depressive Symptoms:
Implications for Treatment
Childhood depression emerges in the context of the family (Hammen, 1995) and
is associated with stressful life experiences (Cicchetti & Toth, 1998; Kronenberger &
Meyer, 2001) and relationship impairments (Dujovne, Barnard, & Rapoff, 1995) that
contribute to the development and maintenance of depressive symptoms (Cicchetti &
Toth, 1998; Kronenberger & Meyer, 2001). Recognition of the relationship between
family variables and the development of depressive symptoms in children (Racusin &
Kaslow, 2004) and the severity and course of symptoms (McCauley & Myers, 1992), has
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potential treatment implications. Specifically, a number of authors have called for greater
inclusion of caregivers in the treatment of depressed children (Hammen, Rudolph, Weisz,
Rao, & Burge, 1999; Stark et al., 1996; Vuchinich, Wood, & Angelelli, 1996).
The psychopathology literature reveals a number of variables which could be
targeted for greater inclusion of caregivers. For instance, a meta-analytic review by
Lovejoy, Grczyk, O'Hare, and Neuman (2000) found that parents of depressed children
are less engaged with the child, engage in fewer positive behaviors towards the child, and
express more hostility and negativity. These results support suggestions that families of
depressed children are often not involved in many fun activities with the child (Lovejoy et
al., 2000; Stark, Ballatore, Hamff, Valdez, & Selvig, 2001; Stark, Sander, Yancy, Bronik,
& Hoke, 2000; Stark et al., 1996). These conclusions indicate that increasing quality time
spent in enjoyable activities between the caregivers and the child may have positive
influences on the child's depressive symptoms and family relations.
Families of depressed children have also been described as providing low levels
of both verbal and nonverbal rewards and reinforcement for adaptive behavior, and
instead may inadvertently reinforce depressive behavior (Sheeber, Hops, & Davis, 2001).
For instance, caregivers may react to their children in ways that promote negative and
depressive behaviors, such as often leaving the child alone, and not encouraging and
reinforcing social engagements and positive behaviors from the child (Messer & Gross,
1995). Depressive behavior may also be passed from parents to children through
modeling of depressive behaviors (Kovacs, 1997). Translating this to the treatment milieu
suggests working with caregivers on ways of detecting and reinforcing positive, adaptive,
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non-depressive behaviors may improve the child's emotional state and may also increase
the occurrence of more positive behaviors. Also, increasing the occurrence of positive
behaviors can provide caregivers with more opportunities to reinforce the child, may
improve the caregiver-child interaction, and may make the home environment more
positive and pleasant, thereby decreasing depressive symptoms.
Childhood depression is also related to dysfunctional and ineffective
communication styles. As such, it is not surprising that families of depressed children are
characterized by the presence of high levels of conflict (Crethar, Snow, & Carlson, 2004;
Garber & Horowitz, 2002; Stark et al., 2005; Stark, Rouse, & Kurowski, 1994; Stark &
Smith, 1995; Stark et al., 1996), criticism, and argumentativeness (Kazdin & Marciano,
1998). Relatedly, it appears that parents of depressed children have difficulty listening to
and expressing emotional support for their children (Stark et al., 2000; Stark & Smith,
1995; Stark et al., 1996), responding sensitively to their children's emotional needs
(Messer & Gross, 1995), and failing to communicate clearly and consistently and resolve
disputes effectively. As such, including the family for communication skills training may
be beneficial (Sanders, Dadds, Johnston, & Cash, 1992). Working on dysfunctional
family interaction characteristics and improving communication may alleviate family
tension and may assist in decreasing the child's depressive symptoms.
In addition to coming from families with decreased positivity, heightened
negativity, and problematic communication styles, depressed children perceive family and
personal decisions as being less democratic (Stark, Humphrey, Crook, & Lewis, 1990). In
families of anxious-depressed children there are more conflicts and less-developed
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problem solving strategies (Nilzon & Palmerus, 1997). Thus, including caregivers for
problem solving training may be beneficial (Sanders et al., 1992). Changes in their
approach to solving problems may help reduce conflict and could strengthen the child's
self-efficacy and facilitate the child's use of coping skills in everyday life. Also, more
productive ways of solving problems may further reduce the negative interaction patterns
between the caregivers and child.
In addition to the importance of including the family in the treatment of depressed
children due to the link between parental characteristics and childhood depression, there
are other potential advantages for including caregivers in the treatment. Fully
understanding each child's depressive symptoms and providing most effective
intervention likely requires an understanding of the home environment and the relation
between the symptoms and the context in which they occur. Parents can provide valuable
information about treatment progress (Verduyn, 2000) and additional information about
the symptoms the child presents with. The information they provide can allow for better
adjustment of the treatment to the child's home environment and individual needs
(Dujovne et al., 1995; Vuchinich et al., 1996). Caregivers are important for assisting the
child in implementing the skills acquired during the individual therapy in the natural,
everyday environment (Stark et al, 2000), supporting the child in making changes in
daily activities (Verduyn, 2000), promoting learning and practice of new skills
(Harrington et al., 1998), and potentially changing aspects of the surroundings that might
be related to the symptoms (Stark et al., 1996). Finally, family involvement for
psychoeducation regarding depression and the treatment may promote better
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understanding of the child and may encourage greater adaptive contact between the
caregivers and the child, helping to decrease depressive symptoms and enhance
relationships and functioning (Sexson, Glanville, & Kaslow, 2001). Recent pilot data
support the approach of including caregivers, suggesting that psychoeducation can
improve relationships within the families of children with mood disorder symptoms
(Fristad, Gavazzi, & Soldano, 1998).
Despite the compelling case for formally including caregivers into the treatment
of depressed children, few empirical studies have done so. Eckshtain and Gaynor (2007b)
conducted a literature review to assess how caregivers have been included in intervention
studies for depressed youth. They identified 64 studies with school-age or adolescent
samples, both prevention and outpatient treatment studies, and found that caregivers were
under-incorporated in intervention studies for depressed youth. In 47% of the studies
caregivers received psycho-education about childhood depression and/or the therapy
provided and in only 36% of the studies were caregivers explicitly included in the
intervention via family sessions, parent training, or parent-child sessions designed to
address family climate and caregiver-child relations. With regard to assessment and
evaluation, they found that in only 56% of the studies did caregivers complete measures
of their child's functioning, in only 14% of the studies did caregivers complete a measure
of intervention satisfaction, and in only 33% of the studies did caregivers or the child
complete measures of family functioning or caregiver-child relations.
To address the lack of caregiver inclusion, Eckshtain and Gaynor (2007a)
conducted an intervention that combines individual CBT with caregiver/caregiver-child
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sessions. They developed four caregiver sessions focusing on positive parenting and
positive caregiver-child interactions. These sessions were added to the PASCET manual,
and include three parent sessions focusing on psychoeducation regarding depression and
the treatment, gathering information from the caregivers regarding the child and the home
environment, and promoting better understanding of the child's condition and the
treatment progress. The six children treated by Eckshtain and Gaynor (2007a) showed
significant reductions in depressive symptoms. Moreover, both caregivers and children
appreciated the additional caregivers' sessions, with most caregivers reporting some level
of improvement in family relationships and greater use of positive parenting practices.
The largest change occurred in the amount of dedicated "special time" caregivers spent
with the child.
The results from this study coalesce with other approaches and suggestions to
increase caregiver involvement in treatment (Asarnow et al., 2002; Fristad et al., 1998;
Fristad, Goldberg-Arnold, & Gavazzi, 2003). Even when the focus of the treatment is
mainly on the child, the family can still potentially benefit from supportive, educational,
and targeted interventions.
McLeod and Weisz (2005) provide another interesting reason for further including
caregivers. Specifically, they found that a strong parent-therapist alliance was related to
improvement in child anxiety and depressive symptoms while a strong child-therapist
alliance was related only to improvement in the child anxiety symptoms. Thus, to the
extent that multiple interactions between the therapist and the caregiver contribute to the
alliance, this could have positive influences on the child's depressive symptoms.
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Statement of Purpose
In the present study, CBT, based on the PASCET manual (Weisz et al., 1999),
was provided in an individual format to 15 children with depressive symptoms.
Individual treatment in a school setting allowed for a specific focus on each child's
behavioral patterns and cognitive habits. It also allowed for increased direct involvement
of primary caregivers (Hammen et al., 1999; Weisz et al, 1997) in a setting that allowed
children to participate who, due to financial, transportation, or other familial
considerations, would not have been able to access services.
In addition, the current study added caregiver sessions. The goal was to target the
above outlined familial deficits to promote better familial relationships and to decrease
the child's depressive symptoms as well to enlist the help of the caregivers in promoting
use and generalization of individual treatment skills outside the session. Changes in
depressive symptoms were analyzed at the group level and with reference to established
cutoff scores on the measures used. In addition, the results were benchmarked against
comparable existing randomized clinical trials. Additional analyses explored changes in
the psychosocial functioning, cognitive style, activity level, coping skills, caregiver-child
relations, and parenting stress. Finally, the role of pre-treatment variables as moderators
and change in the first phase of treatment as predictive of later depression change were
also assessed.

CHAPTER II
METHOD
Participants
Fifteen youth, 10 females and 5 males, between the ages of 8 and 13 (M- 10.27,
SD = 2.02) participated (see Table 1). All participants, along with a custodial caregiver,
were from three elementary schools and one middle school belonging to the Vicksburg
Community Schools. Referrals to the study were made by school counselors. As can be
seen in Table 2, for 26.7% (n = 4) of the participants two caregivers participated, while
the remaining 73.3% (n = 11) had one caregiver that participated.
Referrals were initiated by the schools. When one of the school counselors was
interested in referring a child to the study, she administered the Children's Depression
Inventory (CDI; Kovacs, 1992) to the potential participant. The CDI is a measure that
prior to the proposal of this study has been used in routine practice by Vicksburg
Community Schools to assess depression severity. Consistent with cutoffs recommended
in the literature, potential participants were required to endorse at least mild to moderate
symptoms of depression, as assessed via a score > 12 on the CDI in order to be referred to
the treatment (Szigethy et al., 2004; Weisz et al., 1997). This cutoff criterion resulted in
an average screening CDI score of 20.2 (SD = 8.48) for the included children, with scores
ranging from 12 to 47. If a child did not score 12 or above on the CDI, the child was still
eligible for services from the school counselors, but was not be eligible for consideration
12

Table 1
Demographic Characteristics ofParticipants
Variable
Age
8
9
10
11
12
13
Grade
3rd
4th
5th
6th
^th
th

8
Gender
Male
Female
Race/ethnicity
Caucasian
Multi Racial
Previous Psychotherapy Services
Yes
No
Current use of psychiatric medications
Yes
No
Past use of psychiatric medications
Yes
No
History of sexual abuse
Yes
No
Past involve, of child protective services
Yes
No
# of participants involved in SIB (cutting)
Yes
No

%

n

26.7%
13.3%
26.7%
0%
6.7%
26.7%

(4)
(2)
(4)
(0)
(1)
(4)

26.7%
26.7%
13.3%
0%
13.3%
20%

(4)
(4)
(2)
(0)
(2)
(3)

33.3%
66.7%

(5)
(10)

86.7%
13.3%

(13)
(2)

80%
20%

(12)
(3)

26.7%
73.3%

(4)
(11)

46.7%
53.3%

(7)
(8)

13.3%
86.7%

(2)
(13)

20%
80%

(3)
(12)

13.3%
86.7%

(2)
(13)
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for participation in the study protocol. As will be specified in detail in the procedure
section, if the child scored 12 or above on the CDI, the counselor contacted the child's
caregivers via phone to invite them to be assessed for participation in the study.
To be included in the study, the referred potential participants were required to
score higher than 11 on the CDI when administered by the therapist investigator. This
requirement is consistent with Kovacs's (1992) report that CDI cutoff scores of 11.8 were
associated with Major Depressive Disorder (Kovacs, 1992). The cutoff criterion resulted
in an average group baseline CDI of 17.73 (SD = 7.09). Across the participants the
average baseline scores ranged from 11 to 36. Participants also had an average of 47.4
(SD = 8.04) on the Children's Depression Rating Scale - Revised (CDRS-R; Posnanski &
Mokros, 1996). The mean CDRS-R total score translates to a normed T-score of 67.3 (SD
= 5.38), indicating that depressive disorder is likely.
All the 15 participants who met inclusion criteria completed treatment. None of
the participants expressed an interest to discontinue participation during the course of the
treatment. One participant completed the treatment but, due to caregiver hospitalization in
a rehabilitation program, did not complete the caregiver termination session and the onemonth follow up assessment.
Exclusion Criteria and Excluded Participants
Exclusion criteria were current primary symptoms of a non-depressive disorder
that suggested a more immediate need for alternative services, such as severe conduct
disorder (extreme antisocial and aggressive behavior), schizophrenia-spectrum disorder,
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autism-spectrum disorders, severe/profound mental retardation, intense anxiety, and
family discord. Another exclusion criterion was report of acute suicidality, meaning
suicidal ideation with a plan, means, and level of intent that made the child a high risk
case, based on the suicidality interview and/or unwillingness to sign a no suicide contract
(see Appendix A). Children who were taking medications were eligible if they had been
on the same medication and dose for 2 months prior to enrollment, continued to meet
entry criteria, and consented to the therapist investigator contacting the prescribing
physician to discuss medication management during the study period (see Appendix B).
One child, a 10-year-old female, scored 6 on the baseline CDI following a score of
46 on the screening CDI. Therefore she failed to meet inclusion criteria. She did receive
the treatment following the HSIRB requirement that children who scored above 12 on the
screening CDI and who were still interested in participating in the study, would be
allowed to do so even if their baseline CDI was lower than 11. However, her data were
not included in the analyses. Her CDI and CDRS-R scores remained low at mid-treatment
(2 and 26, respectively), and post-treatment (3 and 19, respectively).
In addition, three children that met inclusion criteria when the school counselor
administered the CDI were excluded. The first child, a 12-year-old female, presented with
prominent family difficulties that required different services. Following a comprehensive
pre-treatment assessment and a baseline CDI of 6, it was concluded that she reported
depressive symptoms when her father, who is divorced from her mother, is not involved
in her life, something that happened sporadically. During the pre-treatment assessment
the father became again involved in her life, which resulted in her presenting no
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depressive symptoms. Based on the mother's report, the father had told her that he
planned to make an effort to take a more active role in raising his daughter, something
that based on the mother's report had not happened before. Following this information
and a consultation with the mother and the school counselor, who had a long history
working with the family, it was decided to wait and have the counselor keep assessing the
father's involvement in the girl's life and its influence on her. The second child, an 11year-old male, presented with severe anxiety that required different services. The third
child, an 11-year-old male, refused to participate in the study. The therapist investigator
worked along with the school professionals and the caregivers to find another referral
source for services if this was desired by the family. The first child was monitored by the
counselor, the second child received services outside the school, and the third child
refused to receive any services.
Sample Characteristics
As can be seen in Table 1,26.7% (n = 4) of the participants were in 3rd grade,
26.7% (#i = 4) in 4th grade, 13.3% (« = 2) in 5th grade, 13.3% (n = 2) in 7th grade, and 20%
(n = 3) in 8th grade. The vast majority, 86.7% (n = 13), of the participants were Caucasian
and 13.3%) (n = 2) multiracial. Large percentage of the participants, 80% {n = 12), had a
history of previous psychotherapy and 46.7% (n = 7) had a history of use of psychiatric
medications. Of these, four used stimulants, two used non-stimulant, two used SSRIs, one
used a selective norepinephrine and dopamine reuptake inhibitor, one used a mood
stabilizer, and one used an antipsychotic medication. During the treatment, 26.1% in = 4)
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were using stimulant medications and met the requirement of using the same medication
and dose for 2 months prior to enrollment and throughout their participation. As can be
seen, 13.3% (n = 2) of the participants, both females, had a history of sexual abuse, and
20% (n = 3) of the children had a past involvement with Child Protective Services.
Involvement in self cutting before treatment started was reported by 13.3% (n = 2) of the
participants.
As can be seen in Table 2, 73.3% (n = 11) of the participants lived in two
caregiver home with 46.7% (« = 7) living with both biological parents, 20% (n = 3) living
with two adoptive caregivers, and 6.7% (n = 1) living with one biological parent and one
step-parent. The remaining 26.7% (n = 4) of the participants lived in a single caregiver
home, with 20% (« = 3) living with their biological mothers and 6.7% (n = 1) living with
biological fathers. For 46.7% {n = 7) of the families the annual income was higher than
75,000, for 20% (n = 3) it was in the range of 50,000 to 75,000, for 13.3% (n = 2) it was
in the range of 25,000 to 50,000, and for 20% (n = 3) it was in the range of 0 to 25,000.
Considering all the caregivers of the participants, 25% (n = 7) either graduated from high
school or had a GED, 10.7% (n - 3) attended college, 17.9% (« = 5) graduated from
Trade School or had a 2-year degree, 14.3% (n = 4) had a Bachelor's degree, and 32.1%
(n = 9) had a post Bachelor's degree. Of the caregivers that participated in the treatment,
31.6% (n = 6) either graduated from high school or had a GED, 5.3% (n = 1) attended
college, 10.5% (n - 2) graduated from Trade School or had a 2-year degree, 15.8% (n =
3) had a Bachelor's degree, and 36.8% (n = 7) had a post Bachelor's degree.
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Table 2
Demographic Characteristics of Caregivers and Families
Variable
Two participating caregivers in the treatment
Total
Both biological caregivers
Both adoptive caregiver
One caregiver participating in the treatment
Total
Maternal caregiver
Biological maternal caregiver
Adopting maternal caregiver
Paternal caregiver (biological)
Two caregiver home
Total
Live with both biological caregivers
Live with adoptive caregivers
Live with one biological caregiver and a stepparent
Single-parent home
Total
Live with biological maternal caregiver and has
visitations with biological paternal caregiver
Live with biological paternal caregiver and has
visitations with biological maternal caregiver
Annual family income
$0-$25,000
$25,000-$50,000
$50,000-$75,000
>$75,000
Education of caregivers
Total
High School graduates / GED
Some college
Trade School / 2 year college
Bachelor degree / 4 year college
Post Bachelors degree
Education of caregivers participating in the treatment
Total
High School graduates / GED
Some college
Trade School / 2 year college
Bachelor degree / 4 year college
Post Bachelors degree

%

26.7%
20%
6.7%

(4)
(3)
(1)

73.3%
66.7%
53.3%
13.3%
6.7%

(11)
(10)
(8)
(2)
(1)

73.3%
46.7%
20%
6.7%

(11)
(7)
(3)
(1)

26.7%
20%

(4)
(3)

6.7%

(1)

20%
13.3%
20%
46.7%

(3)
(2)
(3)
(7)

25%
10.7%
17.9%
14.3%
32.1%

(28)
(7)
(3)
(5)
(4)
(9)

31.6%
5.3%
10.5%
15.8%
36.8%

(19)
(6)
(1)
(2)
(3)
(7)
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Procedure
When school counselors from Vicksburg Community Schools had concerns that a
student was struggling with depressive symptoms, consistent with their existing routine
practice, they administered the CDI (with caregiver's permission) to assess symptom
severity. If the child scored 12 or above on the CDI, the school counselor contacted the
child's caregiver via phone and explained that his/her child appeared to be experiencing
depressive symptoms. They also presented the study protocol as one treatment option,
while indicating that there are other treatment possibilities, including the possibility to be
seen by one of the school professionals. If the caregiver expressed interest in receiving
more information about the treatment study, a general explanation was provided (using a
script; see Appendix C). If the caregiver remained interested, s/he was invited for a
meeting that included the school counselor, the therapist investigator, the caregiver, and,
for a portion of the meeting, the child, to learn more about participating.
Interested caregivers and their children were invited to meet with the therapist
investigator and the school counselor. During the meeting, the study was described in
greater detail (using the consent form; see Appendix D) and a consent form to participate
in the assessment and intervention sessions was reviewed. If the caregiver consented (and
the child assented) to participation, the caregiver and child were asked to sign the consent
document.
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Pre-treatment Assessment
Assessment session 1: Caregiver and child consent and assessment session (60
minutes). The caregiver, the school counselor, and the therapist investigator were present
at the beginning of the meeting to review and explain the study. This explanation was
guided by the consent document (see Appendix D), which was reviewed paragraph by
paragraph with the therapist investigator describing the study details and answering any
question the caregiver had. If the caregiver agreed to participate after reviewing and
discussing the consent form and having his/her questions answered, the caregiver was
asked to initial understanding of the various components of the study and then provide a
signature. Also, the therapist investigator asked for caregiver's permission to give his/her
child small rewards (such as crayons, stickers, pens/pencils) after each assessment session
and during the individual sessions, to which all caregivers verbally consented. In addition,
the therapist asked the caregiver to sign consent for the therapist investigator to talk with
the child's teacher and to release information to school professionals (see Appendix E).
The therapist investigator also asked the caregivers to consent for the therapist
investigator to talk with the child's physician, if their child was taking psychiatric
medication (see Appendix B).
The child was then invited into the room for an explanation of the study. The
therapist investigator and the caregiver together presented the study description at a level
the child could understand. The child was asked if s/he had any questions and these were
answered. After the study description and question/answer period, the child was asked to
sign the consent form. After signing the consent form (see Appendix D), the therapist
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investigator and the child met in the absence of the caregiver. The therapist investigator
summarized the study, emphasizing the collection of assessment information from the
child that would serve to both help directing the intervention and as research data (see
Appendix F). The therapist investigator answered any questions the child had and then
asked the child to assent in writing by providing a signature. The remaining time was
used to begin building rapport and to begin the assessment measurements, including the
suicidality interview, the antisuicide contract (which was also reviewed later together
with the caregiver; see Appendix A), and the CDI. While the child was meeting with the
therapist investigator, the caregiver was asked to complete self-report measures
individually. Due to the amount of time dedicated to the consent process, the entire
assessment with the child was completed in one or two more individual sessions with the
child, which typically occurred within the next several days.
With about 10 minutes remaining in the session the therapist investigator met
again with the caregiver to review and answer any questions about the assessment
measures s/he completed and to provide general impressions. The caregiver was asked to
also sign the antisuicide contract (see Appendix A). The therapist investigator reviewed
the plan for the next several meetings using a handout, which included the treatment
phases and sessions (see Appendix G). The first caregiver session in which the child's
assessment results are summarized in detail and psychoeducation provided was either
scheduled in this meeting or over the phone. Also, the therapist investigator explained
that after every individual session she would call the caregiver to provide information
about the individual session.
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Assessment sessions 2 and 3. Up to two additional assessment sessions with the
child (up to 45 minutes) were scheduled, depending on the amount accomplished in the
first assessment meeting. Allowing for these additional meetings ensured that the
assessment process was not rushed and that time was also taken to build rapport and let
the child move at his/her own pace, and also avoiding having the child miss more than 45
minutes of class.
Teacher assessment session. The therapist investigator met with the child's
teacher at pre-treatment (30 minutes), mid-treatment (10-15 minutes), post-treatment (1015 minutes), and follow-up (10 minutes). These meetings were brief and were conducted
in order to discuss the teacher's impressions of the child, including peer relationships and
behavioral and emotional problems. During the visit the teacher was administered the
Strengths and Difficulties Questionnaire - Teacher and the Academic Functioning Record
Form (detailed explanation about these measures is provided in the measures section),
which together took no longer than 10 minutes to complete. The aim of the meetings was
also to identify resources available to the child at school. All teachers agreed to
participate in the assessment process and signed a consent form (see Appendix H for
consent form and explanation script). If the one-month follow-up assessment was
conducted during the summer vacation, the teacher did not complete this assessment.
Treatment
The individual treatment was based on the Primary and Secondary Control
Enhancement Training (PACSET) manual (Weisz et al., 1999) with several alterations.
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First, the segmenting and structuring of the sessions had to be altered to fit the treatment
manual to the school format and use in 45-minute sessions. Second, one session (focusing
on development of talents and skills) was removed but the skill was briefly reviewed in
the two sessions focusing on increasing enjoyable activities, and another (focusing on
increasing positive self thoughts) was added. The treatment included 16 individual
sessions, each lasting 45 minutes, as specified in Appendix G. The caregiver sessions
included those routinely used in the PASCET manual plus four additional sessions
created to augment the PASCET manual and are included in the Caregiver-Child
Relationship Enhancement Training (C-CRET; Eckshtain & Gaynor, 2003) manual. The
treatment included seven caregiver sessions, each lasting 60 minutes, delivered over a
period of eight weeks, as specified in Appendix G.
PASCET. The PASCET program is a structured intervention, for children aged 8
to 15. The treatment program is based on a two-process model of control, the primary and
secondary control model of change. According to this model, primary control involves
enhancing reward or reducing punishment by making, to the extent possible, objective
conditions conform to the individual child. Secondary control involves enhancing receipt
of rewards or reducing punishment by adjusting oneself to fit objective conditions so as to
influence their subjective impact without altering the events themselves. Primary control
is applied to distressing conditions that are modifiable whereas secondary control is
applied to those conditions that are not (Weisz et al., 1999; Weisz et al., 2003; Weisz et
al., 1997).
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The treatment, according to this model, focuses on behavioral and cognitive
features of depression and is based on a social learning conceptualization of depression
called the skills and thoughts (SAT) theory (Weisz et al., 1999). According to SAT
theory, skills deficits (e.g., poor activity selection) and cognitive habits (e.g., negative
depressogenic cognitions) can decrease the child's mood and increase the likelihood that
the child would respond to negative, stressful, or ambiguous life events, in a way that
contributes to the development of depressive symptoms. In addition, the child's tendency
to respond to adverse life events negatively, and in a way that promotes depressive
symptoms, can create events that are stressful and negative as a result of the response
style, which then further exacerbates the child's depression, creating a depressogenic
cycle from which it is hard to escape. As such, PASCET attempts to teach children
coping skills that promote primary and secondary control.
Combination of PASCET and C-CRET. At least one (and both if possible)
caregiver was incorporated into the treatment (see Table 2 for information of caregivers
that participated in the study) through individual caregiver meetings and caregiver-youth
conferences. In addition to addressing specific skills, the caregiver meetings served the
general functions of keeping the caregivers informed about the treatment, allowing for
feedback regarding how the child was doing outside the treatment setting, and building
and maintaining rapport with the caregivers.
Treatment started with a caregiver orientation session providing psychoeducation
regarding childhood depression and the treatment. Four additional sessions were added to
what is typically offered in the PASCET. These caregiver sessions served the specific
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function of more fully engaging the caregiver in the change process by teaching strategies
for use in the home. These additional sessions were conducted with the caregiver and/or
with the caregiver and the child and focused on increasing the amount of positive time
spent together between the caregivers and the child, increasing reinforcement of positive
mood and positive behaviors, enhancing positive communication and empathic listening
and support, familial communication, and problem solving.
In addition, caregiver conferences, similar to those prescribed in the PASCET
manual, took place after each individual child meeting. After each individual session the
therapist investigator called the caregiver for a 5-minute therapist-caregiver phone
conference. In the conference the main points of the individual sessions were discussed,
the child's practice assignments were described, and the caregiver was encouraged to
assist the child with the practice assignment. During the conference the therapist
investigator asked the caregiver to follow the caregiver handout while receiving the
summary. The handouts, which kept the caregiver apprised of the coping strategies being
taught, the child's practice assignments, and ways the caregiver could help, were given to
the caregiver in the first caregiver session. There were two main objectives for these
conferences. The first objective was to give the caregiver continuous reminders of the key
coping skills being taught to the child, and thus to give the caregiver the knowledge base
needed to support the child's efforts outside the therapy office. The second objective was
to keep the caregiver apprised of and engaged in the treatment process, and thus
motivated to help.
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Treatment-phase I (see Appendix G). This phase of treatment consisted of seven
individual sessions with the child covering the AC of the ACT & THINK chart. Each
individual session had specific goals and objectives and included home practice
assignments to promote generalization and independent use of strategies. After the skill
was taught, the therapist investigator and the child engaged in a fun activity. The
treatment also included a practice book for the child, which included in-session activities
and home practice assignments.
The main objectives of the first session were to continue building the therapeutic
alliance, to discuss the purpose and process of the sessions, to introduce the main ideas of
the program, and to explain the ACT & THINK chart. The main objective of the second
session was to teach problem solving skills. The main objectives of the third and forth
sessions were to convey the link between activities and feelings, and to discuss different
kinds of activities that can help the child to feel better. The main objective of the fifth
session was to present strategies for staying calm and relaxed. The main objective of the
sixth and seventh sessions was to discuss presentation of positive self in interactions with
others. After each individual session there was a 5-minute therapist-caregiver phone
conference.
Phase I also consisted of three sessions with the caregivers. These sessions were
based on the combination of the C-CRET manual and the PASCET manual. The first
session, based on the PASCET manual, took place at the beginning of the treatment
before the first individual session with the child. This session addressed issues related to
caregiver involvement, confidentiality, and psychoeducation regarding the treatment
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program and childhood depression. During the session, the caregiver also received the
handouts regarding the child treatment sessions, which the therapist investigator asked
him/her to look at during the therapist-caregiver phone conferences. The second session,
based on the C-CRET manual, took place after the first individual child session. The first
part of this session was conducted with the caregiver and the child and focused on
creating a scheduled special time between the caregiver and child in the home. The
second part of the session involved only the caregiver and focused on non-contingent
positive attention (praise). The third part of the session was conducted with the caregiver
and the child and focused on positive communication. The third caregiver session, based
on the C-CRET manual, took place after the third individual child session. This session
focused on positive behavior management procedures; that is, on reinforcing positive
mood and positive behaviors.
Mid-treatment assessment. After Phase I of the treatment, there was a midtreatment assessment. The caregiver, the child, and the teacher measures were readministered to assess initial progress of the child. The format was similar to the pretreatment assessment procedure.
Treatment-phase II (see Appendix G). This part consisted of nine individual
meetings with the child covering the T and THINK from the ACT &THINK chart. Each
individual meeting, again, had specific goals and objectives and included home practice
assignments to promote generalization and independent use of strategies. After the skill
was taught, the therapist investigator and the child engaged in a fun activity. Again, the

28
treatment included a practice book for the child, which included in-session activities and
home practice assignments.
The main objectives of the 8th and 9th sessions were to make the connection
between thoughts and feelings and to work on identifying and changing negative thinking
patterns. The main objectives of the 10th and 11th sessions were to make the connection
between thoughts and feelings and to work on identifying and changing negative selfthoughts into positive self-thoughts. The main objectives of the 12th session were to
demonstrate and practice things that can be done to feel better when bad things happen
that cannot be changed, including identifying the silver lining, sharing things with a
trusted person, and reviewing ways to distract from negative thoughts. Sessions 13 to 16
combined all the previous skills taught (the primary and secondary control) and matched
them to the specific needs of each child. The main objectives of the 13th session were to
practice backup plans in case a coping attempt fails and to stress importance of
persevering in coping attempts. The main objectives of the 14th and 15th sessions were to
work on personalizing the ACT & THINK chart and to identify the "best fit" coping skills
for the individual child. In addition, the therapist investigator discussed and shared the
current case formulation with the child while preparing for these sessions. These sessions
also focused on assisting the child in being more fluent in using the ACT & THINK
skills. These sessions tried to focus on the particular skill deficits or habits of thought that
appeared most relevant for the specific child being treated, and that the therapist
investigator and/or the child saw as not fully practiced and/or fluent after the first 12
sessions. That is, the sessions focused on practicing applying the most personally relevant
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PACSET coping skills to the actual life situation of the child and were aimed at helping
the child to select the primary and secondary coping skills and strategies that seemed
most relevant personally and most likely to be helpful. The appropriate PASCET skills
for these sessions were identified by the therapist investigator and the child through the
analysis of the child's responses to the various exercises and practice assignments
throughout the previous and current sessions. The final individual 16th session was past
and future oriented. The therapist investigator and the child reviewed the main lessons of
the PASCET program, including the specific skills that fit the child best. The therapist
investigator anticipated, together with the child, the potential depressogenic situations and
life events that are most likely to arise in the future for the child, and developed specific
plans for what the child can do to cope when these situations arise. Again, after each
individual session there was a 5-minute therapist-caregiver phone conference.
Phase II also consisted of four structured manualized meetings with the caregiver.
These sessions were based on the combination of the C-CRET manual and the PASCET
manual. The 4th session, based on the PASCET manual, was conducted after the midtreatment assessment and before the 8th session with the child. The session was
conducted with the caregiver and included review of the case formulation and midtreatment assessment results, progress and current status, assessment of caregiver'
perception regarding the child's current emotional state and progress in the program, and
review of the PASCET concepts that had been covered up to this point in the treatment.
The 5th caregiver session, based on the C-CRET manual, took place after the 9th
individual child session. The session involved only the caregiver and focused on
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communication training. The 6th caregiver session, based on the C-CRET manual, took
place after the 11th individual child session. The session involved both the caregiver and
the child and focused on teaching family problem solving. The 7th caregiver session,
based on the PASCET manual, included review of the case, progress and current status;
review of the final case formulation of the child; review of the main lessons of the
treatment program; and recommendations for future, based on the treatment, including
plans for specific situations and future therapy. This session was conducted with the
caregiver and took place at the end of the treatment, and before the final session with the
child.
Measures
Clinician Measures
Children's Depression Rating Scale - Revised (CDRS-R; Poznanski & Mokros,
1996). The CDRS is a semi-structured interview that assesses 17 symptom areas,
including depressed mood, difficulty having fun, irritability, suicidal ideation, morbid
ideation, excessive weeping, low self-esteem, social withdrawal, sleep disturbance,
excessive fatigue, appetite disturbance, physical complaints, excessive guilt, impaired
schoolwork, depressed facial affect, listless speech, and hypoactivity. Scores of 29 or
lower indicate that depressive disorder is unlikely, scores between 30 and 42 indicate that
depressive disorder is possible, and scores of 44 or higher are indicative of depressive
disorder. Scores, based on ratings by interviewers, have shown acceptable internal
consistency (.85) and test-retest reliability (.80), and evidence of validity (Ponanski &
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Mokros, 1996; cf. Weisz et al, 1997). The therapist investigator administered the CDRSR, which takes 30-45 minutes, to the child at pre-treatment, mid-treatment, posttreatment, and one-month follow-up.
Due to the fact that the interviewer was not independent, 19% (13 of 67 and 221
individual items) of the CDRS-R interviews (including pre-treatment, mid-treatment, and
post-treatment interviews), selected randomly, were observed and scored by a separate
coder. The coder was an advanced undergraduate psychology major who worked as a
research assistant. The coder was trained in the administration of the CDRS-R by the
therapist investigator, who conducted the interviews. After didactic training the therapist
investigator and the coder watched the pre-treatment CDRS-R interview with the child
whose data were excluded from analysis to ensure initial reliability. In addition,
throughout the coding, the coder was instructed to consult with Dr. Gaynor regarding any
difficulties in scoring. In assessing agreement related to the specific items on the CDRSR, kappa (n = 221) was .54 (p < .000), which is considered a fair agreement (Watkins &
Pacheco, 2000). However, the correlation between interview and coder scores was very
high {r = .87, p < .000), indicating that while the scores for the therapist investigator and
the coder did not match exactly, they were very close and usually differed by one point
higher or lower. This is further evident in the correlation between total CDRS-R scores,
which was r = .99, p < .000. These data suggest that the interviewer, who was also the
therapist, was not selectively attending to information and possibly inadvertently biasing
results when conducting the CDRS-R.
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Children's Global Assessment Scale (C-GAS; Shaffer et al., 1983). The C-GAS is
a clinician measure of functioning of children and adolescents and provides a global
rating on a scale of 0 to 100. The clinician rates the child's most impaired level of general
functioning on a hypothetical continuum of health-illness. The therapist investigator rated
the child's functioning at pre-treatment, mid-treatment, post-treatment, and one-month
follow-up.
Child Measures: Depression
Children's Depression Inventory (CDI; Kovacs, 1992). The CDI is an adaptation
of the Beck Depression Inventory (BDI) and is the most commonly used self-report
measure of depression for children 7 to 17 years old (Kaslow, Stark, Printz, Livingston, &
Ling-Tsai, 1992). The CDI consists of 27 items assessing the presence and severity of
symptoms of depression over the two weeks prior to the assessment. Each CDI item
consists of three choices, keyed 0,1, or 2, with higher scores indicating greater severity.
The CDI total score can range from 0 to 54. Scores above 9.5 indicate adjustment
disorder with depressed mood and scores above 11.8 indicate major depressive disorder
(Kovacs, 1992). However, in a normative study of the CDI with a sample of 1,252
subjects between the ages of 8 and 16, the average score was 9.09 (Smucker, Craighead,
Craighead, & Green, 1986). The CDI is reported to have good internal consistency
(ranges from .71 to .89; Kovacs, 1992) and a test-retest reliability coefficient of .82 for
two week intervals and .66 and .67 for longer intervals of four and six weeks (Finch,
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Saylor, Edwards, & Mcintosh, 1987). Children completed the CDI at pre-treatment, midtreatment, post-treatment, and one-month follow-up.
Child Measures: Coping Skills
Self-Report Coping Scale (SRCS; Causey & Dubow, 1992). The SRCS is a 34item self-report measure that assesses children's coping strategies when coping with two
specific problems ("When I get a bad grade in school, one worse than I normally get, I
usually..." and "When I have an argument or afightwith a friend, I usually..."). The
SRCS is based on the approach/avoidance conceptualization and assesses five coping
sub-domains/scales, two approach scales (seeking social support and problem solving)
and three avoidance scales (distancing, internalizing, and externalizing). Responses to
items range on a 5-point Likert scale from 1 {never) to 5 {always) with higher scores on
the approach scales indicating positive and adaptive coping skills and lower scores on the
avoidance scales indicating positive and adaptive coping skills. Total score ranges from
34-170, with higher scores indicating more productive coping skills. Psychometric
analyses have shown internal consistencies of the subscales ranging from .69 to .82 for
Coping with a Poor Grade and from .68 to .84 for Coping with a Peer Argument. Twoweek test-retest reliabilities for Coping with a Poor Grade are .73 for Seeking Social
Support, .60 for Problem Solving, .64 for Distancing, .63 for Internalizing, and .69 for
Externalizing; and for Coping with a Peer Argument are .72 for Seeking Social Support,
.64 for Problem Solving, .58 for Distancing, .59 for Internalizing, and .78 for
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Externalizing. Children completed the SRCS at pre-treatment, mid-treatment, posttreatment, and one-month follow-up.
Child Measures: Cognitive Habits
Automatic Thoughts Questionnaire - Short Form (ATQ-SF; Hollon & Kendall,
1980). The ATQ is a self-report measure that assesses the frequency of occurrence of
automatic negative self-thoughts. Responses to items range on a 5-point Likert scale from
1 (never) to 5 (always) with higher scores indicating increasing severity. Although the
ATQ was originally developed for college students (Hollon & Kendall, 1980), the ATQ
also showed high criterion validity with depressed children and acceptable levels of
internal consistency with children aged 6 to 13 (Kazdin, 1990). In addition, the ATQ was
used with adolescents aged 12 to 17 and was able to discriminate depression among
psychiatric and nonpsychiatric populations (Kauth & Zettle, 1990). In the current study
we used a short version of the ATQ, which consisted of the 10 items that had the highest
item-to-total correlation in the Kazdin (1990) study. On this short version, scores could
range from 10 to 50 with higher scores indicating greater negative self-thoughts. Scores
above 20 were considered indicative of the abnormal range. Children completed the
ATQ-SF at pre-treatment, mid-treatment, post-treatment, and one-month follow-up.
Cognitive Triad Inventory for Children - Short Form (CTI-C-SF; Kaslow et al.,
1992). The CTI-C is a self-report measure consisting of 36 items (to which responses are
yes, no, or maybe), from three scales: view of the self, view of the world, and view of the
future. The CTI-C has demonstrated acceptable internal-consistency and solid concurrent
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validity (Kaslow et al., 1992). The current study used a short version of the CTI-C, which
consisted of the 10 world and future items that had the highest item-to-total score
correlations in the Kaslow et al. (1992) study. As such, the total score could range from 0
to 20 with higher scores indicating less negative cognitions. Scores of 11 or lower were
considered indicative of abnormal range. Children completed the CTI-C-SF at pretreatment, mid-treatment, post-treatment, and one-month follow-up.
Child Measures: Activity Level
Self-Report Activation Level (SRAL). The SRAL is a self-report measure
consisting of 12 items assessing involvement of the child in different activities and skills
targeted in the first part of the treatment both with the child and the caregiver. The SRAL
was developed for the current study and uses a 4-point Likert scale from 1 {not at all
during the last week) to 4 (many times during the last week). Scores range from 12 to 48
with higher scores indicating higher level of activation and involvement in skills targeted
in the first part of the treatment. The SRAL was administered at pre-treatment, midtreatment, post-treatment, and one-month follow-up.
Child Measures: Family Relationships
Parent-Child Relationship Questionnaire - Child Version - Short Form (PCRQC-SF; Furman, 2001). The PCRQ is a measurement assessing five areas (scales) of
parent-child relations including warmth between the caregiver and the child, closeness,
use of positive disciplinary strategies, parental power assertion, and possessiveness. The
children were administered a short version of the full measure that included 40 items and
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rated their answers on a 5-point Likert scale from 1 {Hardly at all) to 5 (extremely much).
Higher scores on scales 1 to 3 indicate positive parenting and lower scores on the last two
scales indicate positive parenting. Total scores range from 40 to 200 with higher scores
indicating a better relationship between caregiver and child and more positive parenting
skills. Alphas for the factors range from .68 to .88 (M= .81; Furman, 2001). The PCRQ
also offers a parent version, which was administered to the caregivers in its full 57-item
version. The children completed the PCRQ-C-SF at pre-treatment, mid-treatment, posttreatment, and one-month follow-up.
Caregiver Measures: Demographic Information
Child Clinician's Intake Summary Form. This measurement assesses general
demographic information including the child's presenting problem, medical history,
social history, academic history, major stressors and coping strategies, and family history.
This measurement was completed only at pre-treatment, with the exception of the section
on the Child's Coping Strategies Under Stress, which will be explained in detail in the
following paragraph. Family income was assessed on a separate recording form.
Caregiver Measures: Child's Coping Skills
Child Coping Skills Under Stress (CCSUS). This measurement is a part of the
Child's Clinician's Intake Summary Form. The CCSUS assesses both positive and
negative coping skills of the child. Scores range from 0 to 1, with higher scores indicating
more positive coping skills. It was administered at pre-treatment (as part of the Child
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Clinician's Intake Summary Form), mid-treatment, post-treatment, and one-month
follow-up.
Caregiver Measures: Child's Depression, Behavior, and Social Skills
Strengths and Difficulties Questionnaire - Parent Form (SDQ-P; Goodman,
1999). The SDQ-P is 25-item inventory that produces a total score and is also divided
between five scales of five items each, assessing conduct problems, hyperactivity,
emotional symptoms, peer problems, and prosocial behavior. The scores fall under one of
three categories: Abnormal/High Difficulties, Borderline/Medium Difficulties, and
Normal/Low Difficulties (Bourdon, Goodman, Rae, Simpson, & Koretz, 2005). There are
three scales calculated for the current study. The first is the total difficulties with
abnormal scores (9% of the population) ranging from 16 to 40, borderline scores (9% of
the population) ranging from 12 to 15, and normal scores (82% of the population) ranging
from 0 to 11 (Bourdon et al., 2005). The second is the impact of the difficulties on the
child's life (i.e., impairment) with abnormal scores (8% of the population) ranging from 2
to 10, borderline scores (4% of the population) of 1, and normal scores (88% of the
population) of 0 (Bourdon et al., 2005). The third is the estimated likelihood of a child
having any diagnosis according to the DSMwith three possible predictions: "low risk,"
"medium risk," and "high risk" (http://sdqscore.net). Test-retest reliability on the SDQ
ranges from .70-.85 and internal consistency from .51-.76 (Goodman, 1999). The
caregivers completed the SDQ-P at pre-treatment, mid-treatment, post-treatment, and
one-month follow-up.
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Caregiver Measures: Caregiver Stress Level
Parenting Stress Index - Short Form (PSI-SF, Abidin, 1995). The PSI-SF is a
direct derivative of the Parenting Stress Index full-length test. The PSI-SF is a 36-item
scale that was designed to measure the amount of stress the parent is experiencing. The
PSI-SF was developed based on the notion that the total stress a parent experiences is a
function of certain characteristics of the child, the parent, and situations related to the role
of being a parent. Therefore, the PSI-SF total score is composed of three domains of
stress: parent distress, parent-child dysfunctional interaction, and difficult child. The PSISF is reported to have acceptable test-retest reliability of .84 for the total score and a
range of .68 to .85 for the subscales scores. The PSI-SF is a short version of the long PSI
and has a correlation of .94 with it. The PSI-SF was administered at pre-treatment, midtreatment, post-treatment, and one-month follow-up.
Caregiver Measures: Family Relationships
Parent-Child Relationship Questionnaire - Parent Version (PCRQ-P; Furman,
2001). The PCRQ is a measurement assessing five areas (scales) of parent-child relations
including warmth between the caregiver and the child, closeness, use of positive
disciplinary strategies, parental power assertion, and possessiveness. The PCRQ-P
includes 57 items with answers rated on a 5-point Likert scale from 1 (Hardly at all) to 5
(extremely much). Higher scores on scales 1 to 3 indicate positive parenting and lower
scores on the last two scales indicate positive parenting. Total scores range from 57 to
285 with higher scores indicating a better relationship between caregiver and child and
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more positive parenting skills. Alphas for the factors range from .68 to .88 (M= .81;
Furman, 2001). The PCRQ also has a child version, which was administered to the
children in its short version. The caregivers completed the PCRQ-P at pre-treatment, midtreatment, post-treatment, and one-month follow-up.
Caregiver Measures: Caregiver Satisfaction
Client Satisfaction Questionnaire (CSQ, Larsen, Artkisson, Hargreaves, &
Nguyen, 1979). The CSQ consists of eight items measuring client satisfaction with
treatment. The CSQ has been reported to have high internal consistency (Larsen et al.,
1979). The caregivers completed the CSQ at post-treatment.
Teacher Measures: Depression, Behavior, and Social Skills
Strengths and Difficulties Questionnaire - Teacher Form (SDQ-T; Goodman,
1999). The SDQ-P is 25-item inventory that produces a total score and is also divided
between five scales of five items each, assessing conduct problems, hyperactivity,
emotional symptoms, peer problems, and prosocial behavior. The scores fall under one of
three categories: Abnormal/High Difficulties, Borderline/Medium Difficulties, and
Normal/Low Difficulties (Bourdon et al., 2005). There are three scales calculated for the
current study. The first is the total difficulties with abnormal scores (9% of the
population) ranging from 16 to 40, borderline scores (9% of the population) ranging from
12 to 15, and normal scores (82% of the population) ranging from 0 to 11 (Bourdon et al.,
2005). The second is the impact of the difficulties on the child's life (i.e., impairment)
with abnormal scores (8% of the population) ranging from 2 to 10, borderline scores (4%
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of the population) of 1, and normal scores (88% of the population) of 0 (Bourdon et al.,
2005). The third is the estimated likelihood of a child having any diagnosis according to
the DSM with three possible predictions: "low risk," "medium risk," and "high risk"
(http://sdqscore.net). Test-retest reliability on the SDQ ranges from .70-. 85 and internal
consistency from .51-.76 (Goodman, 1999). Test-retest reliability ranges from .70-.85 and
internal consistency from .51-.76. The child's primary teacher(s) completed the SDQ at
pre-treatment, mid-treatment, post-treatment, and one-month follow-up (when it was
conducted during the school year but not when it was conducted during summer
vacation).
Teacher Measures: Academic Functioning
Academic Functioning Record Form. The child's main teacher(s) completed a
form assessing the child's academic functioning to assess change throughout the
treatment. The teachers completed the form at pre-treatment, mid-treatment, posttreatment, and one-month follow-up (when it was conducted during the school year but
not when it was conducted during summer vacation).
Experimental Design and Analytic Strategy
All participants (JV= 15) received PASCET plus C-CRET. No concurrent waitlist
group was utilized. As such, the study used an open clinical trial design so that all eligible
participants received the treatment and there was no control condition and no
randomization to alternative treatments. Such designs are useful in what are termed
effectiveness studies. Effectiveness studies place a greater emphasis on external validity,
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focusing on how well a treatment with empirical support in randomized clinical trials
(which have higher internal validity) does when applied under more naturalistic, less
controlled, conditions. The present study had endeavored to use inclusion and exclusion
criteria that were as open as possible to evaluate the effects of the treatment with the type
of population that is likely most in need of intervention (and may not be able to access
services otherwise or in more restrictive studies).
Based on the design, including recognition of its limitations, three analytic
approaches were taken. First, change at the group level was investigated using the
Friedman test. The sample size was relatively small for exploring group changes, which
posed a number of potential concerns. The small sample size would limit statistical
power, increasing the possibility of making Type II errors; however, the small sample size
would also allow for extreme scores to dramatically alter group means such that use of
parametric statistics could also lead to Type I errors. Moreover, parametric statistics
assume the dependent variables approximate a normal distribution, a questionable
assumption with small samples. Therefore, based on these considerations, group-level
analyses were conducted using nonparametric Friedman tests. Friedman tests are the
nonparametric equivalent of one-way within-subjects repeated measures analysis of
variance. This test is recommended with small samples because it does not assume
dependent variables are normally distributed and, because it relies on ranks, is less
vulnerable to the influence of extreme scores. These considerations in combination with
the small sample size make this a generally conservative approach.
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In addition, we used the non-parametric alternative to the repeated measures
paired-samples t test, Wilcoxon signed-ranks test, to assess difference between posttreatment and one-month follow-up. This test also converts scores to ranks and compares
them at time 1 and time 2. No statistically significant differences between post-treatment
and one-month follow-up would indicate that any statistically significant change detected
by the Friedman test during the treatment was maintained.
When assessing changes in teachers' report, six of the 15 participants had more
than one teacher reporting on their psychosocial functioning. Therefore, when assessing
change at the group-level across the assessment periods and conducting group-level
analyses using nonparametric Friedman tests and Wilcoxon tests, we calculated the
reports in three different ways. The first was to average the reports of the teachers.
However, to be conservative and to make sure that more extreme scores reported by the
teachers were represented, we also took the scores of the teachers that reported the best
functioning at pre-treatment and the teachers that reported the worst functioning at posttreatment.
Teachers reported the participants' grades for all or most subjects at all
assessment points, excluding situations where one-month follow-up assessment was
conducted during the summer vacation. Two teachers did not report grades at two of the
assessment points and therefore there are 13 cases at pre-, mid- and post-treatment, and
nine cases at one-month follow-up. The grades were averaged to create one grade for each
assessment point and change at the group level was investigated using the Friedman test.
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A Wilcoxon signed-ranks test was also used to assess the difference between posttreatment and one-month follow-up.
The second analytic approach that was used was a benchmarking strategy. To
employ this strategy, published clinical trials for depressed children of a similar age range
that used the same primary dependent variables (CDI and CDRS-R), similar inclusion
criteria, and a roughly similar treatment timeline to the current study, were identified.
This yielded four randomized clinical trials, including De Cuyper et al. (2004), Liddle and
Spence (1990), Stark et al. (1987), and Weisz et al. (1997), all of which included one or
more CBT treatments and one or more control conditions. The treatment outcome data
from the CBT (including PASCET, Social Competence Training, and Self Control; see
Appendix I) and control (waitlist and attention placebo; see Appendix I) conditions were
used to create two composite benchmarks, one indexing the mean effect of the CBT
groups across the studies and the other indexing the mean effect of the control groups
across studies. As can be seen in Appendix I, for the CBT and the control benchmarks, all
studies contributed to the mean CDI benchmark at pre-treatment and post-treatment.
However, at follow-up, the mean CDI was divided into three groups and not all studies
contributed data to all groupings. The groupings with the contributing studies in
parentheses were: 1- to 3-month follow-up (Liddle & Spence, 1990; Stark et al., 1987), 4to 6-month follow-up (De Cuyper et al, 2004), and 7- to 9-month follow-up (Weisz et al.,
1997). As can be seen in Appendix I, for the CBT and the control benchmarks, only Stark
et al. (1987) and Weisz et al. (1997) were available to compute a mean CDRS-R
benchmark at pre-treatment and post-treatment. At follow-up, the mean CDRS-R was
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divided into two benchmarks with Stark et al. (1987) being the 1- to 3-month follow-up
and Weisz et al. (1997) being the 7- to 9-month follow-up. Within-group effect sizes on
the CDI and CDRS-R were also calculated for the PASCET+C-CRET, benchmarked
CBT, and benchmarked control groups.
In addition, we identified two randomized clinical trials comparing fluoxetine
(Prozac) and placebo for the treatment of depressed children. Fluoxetine trials were
selected because it is the only medication approved by the Food and Drug Administration
(FDA) for use to treat depression in children age 7 and older. The studies included were
Emslie et al. (1997) and Emslie et al. (2002). The participants were similar in age range,
and the studies used the same primary dependent variable (CDRS-R), similar inclusion
criteria, and a roughly similar treatment timeline to the current study (see Appendix J).
We used the treatment outcome data from the fluoxetine and placebo conditions to create
two composite benchmarks, one indexing the mean effect of thefluoxetinegroups across
the two studies and the other indexing the mean effect of the placebo groups across the
two studies. As can be seen in Appendix J, for the fluoxetine and the placebo
benchmarks, both studies were available to compute a mean CDRS-R benchmark at pretreatment and post-treatment.
Finally, moderators and within treatment predictors of change of depressive
symptoms (CDI and CDRS-R) were assessed using the age of the participants, gender,
income, past use of psychiatric medications, participants' pre-treatment negative thoughts
(ATQ-SF and CTI-C-SF), coping skills (CCSUS), psychosocial functioning (SDQ-P of
maternal caregiver and SDQ-T), caregiver-child relations (PCRQ-C-SF and PCRQ-P of
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maternal caregivers), and maternal caregivers' stress level (PSI-SF) as potential
moderators. Two additional moderators that were assessed were child compliance with
the treatment and caregiver compliance with the treatment as documented by the therapist
investigator on the Therapist Record Forms. Also, analyses were conducted to assess
whether change in depressive symptoms (CDI and CDRS-R) in the second part of the
treatment could be predicted by change in the first part of the treatment in psychosocial
functioning (SDQ-P of maternal caregivers), negative thoughts (ATQ-SF and CTI-C-SF),
coping skills (SRCS and CCSUS), activation level (SRAL), caregiver-child relations
(PCRQ-C towards both caregivers and PCRQ-P of maternal caregivers), and maternal
caregivers' stress level (PSI-SF). We did not assess moderators of change or predictors of
change related to the paternal caregivers' measures as their number (n - 5) was too small.
Treatment Integrity
All treatment sessions were conducted by the first author (DE), a doctoral student
in the clinical psychology program, who has completed graduate courses in
psychotherapy, child therapy, family therapy, adult therapy, advanced behavior
assessment, personality assessment, intellectual assessment and neuropsychological
assessment. She also has experience working with children at the WMU Psychology
Clinic, in the Department of Pediatrics at the Kalamazoo Center for Medical Studies, and
in the MSU / KCMS Pediatric Hematology-Oncology Children's Multidisciplinary
Specialty Clinic conducting both assessments and cognitive-behaviorally focused
treatment. In addition, she has administered a very similar treatment as part of her thesis
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to six children and their caregivers. Furthermore, she received weekly supervision from
the second author (SG), a licensed clinical psychologist with research and clinical
experience using CBT with youths.
To assess treatment adherence, after every individual meeting with the child
and/or meeting with the caregiver, the therapist investigator completed a session-rating
form, accompanying the PASCET and the C-CRET manuals, called the Therapist Record
Form (TRF). The PASCET's TRFs were taken directly from the PASCET manual
developed by Weisz et al. (1999) (with modifications to fit the changes to the session
structure made to accommodate delivery in the school setting), while the C-CRET's TRFs
were developed for the current treatment using the same general format as the PASCET
TRFs.
As a check, all sessions were videotaped and 17% of them were reviewed by one
coder with 3% reviewed by two coders. The coders were three graduate students in a
Ph.D. program in clinical psychology. The coders watched the session tapes
independently and completed the Therapist Record Form. The sessions were chosen
randomly with the restriction that for each participant one session had to come from the
first five individual sessions, one from sessions 6-10, one from sessions 10-15, and one
caregiver session from the four C-CRET sessions (the selected sessions are listed in
Appendix K). To determine therapist adherence with the manuals, the therapist
investigator's and the coders' TRFs were compared on the questions relevant to the
therapist. Both the amount of agreement between the therapist investigator and the coders
and the level of adherence coded were calculated. To determine child and caregiver
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adherence, the therapist investigator's and the coders' TRFs were compared on the
questions relevant to the child and caregiver, respectively. Again, both the amount of
agreement between the therapist investigator and the coders and the level of adherence
coded were calculated.
When calculating Kappas, scores were evaluated using ranges defined by Watkins
& Pacheco (2000). A Kappa score < .40 was considered poor agreement, a Kappa score
of .40-.59 was considered fair agreement, a Kappa score of .60-.74 was considered good
agreement, and a Kappa score of .75-1.0 was considered very good agreement.
As mentioned above, in addition to assessing agreement between the therapist
investigator and the coders, level of adherence was also calculated. The TRFs were
scored such that higher scores represented better adherence of the therapist investigator,
caregiver, or child with the manuals. For calculating treatment adherence the actual total
scores rated by the therapist investigator, the actual total scores coded by each of the
coders, and the actual total scores rated by all coders (if two coders coded the session the
average between their codings was taken) for each sessions coded, were each divided by
the total possible score for that session to determine level of adherence. The result ranged
from 0 (no adherence) to 1 (perfect adherence) for each rated session for the therapist,
child, and caregiver.
Therapist compliance with the individual treatment assessed whether the therapist
investigator covered the topic(s) of the sessions and whether the participant understood
the topics covered in the sessions and how to implement them, and whether the
participant understood the home assignment. Codings for these questions ranged from 0
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(not covered in the session or did not understand for the child) to 2 (fully understood).
Codings for the individual sessions also included assessing whether the therapist followed
requirements of the PASCET manual including assessing the participant's mood at the
beginning of the session, doing a fun activity at the end of the session, and doing the quiz
about PASCET in session 14. Codings for each of these three questions were either 0 (did
not follow) or 1 (followed). Therapist compliance with the caregiver sessions assessed
whether the therapist investigator covered the topic(s) of the sessions and whether the
caregiver and the child (whenever the child joined to the caregiver sessions) understood
the topics covered in the sessions and how to implement them, and whether the caregiver
understood the home assignment. Codings for these questions ranged from 0 (not covered
in the session or did not understand) to 2 (fully understood). Also, it assessed whether the
caregiver was present in the session, which was coded as either 0 (no one was present) or
1 (one of the caregivers was present).
In assessing agreement, comparison between the therapist investigator and the
three coders together produced 86% agreement (« = 447), with Kappa = .72 (p < .000),
suggesting good agreement between the therapist and the coders. Examination of the
agreement between the therapist investigator and each of the coders suggests good to very
good agreement with all of them. Comparison with coder 1 produced 93% agreement in =
88) with Kappa = .85 (p < .000). Comparison with coder 2 produced 82% agreement {n =
153) with Kappa = .64 (p < .000). Comparison with coder 3 produced 87% agreement («
= 208) with Kappa = .73 (p < .000).
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For therapist adherence, the average therapist investigator's coding (n = 303) was
.94 (SD = .12) and the average coders' coding (n = 52) was .91 (SD = .19). Coder l's
average coding (n = 12) was .95 (SD = .12), coder 2's average coding (n = 20) was .90
(SD = .14), and coder's 3's average coding (n = 29) was .89 (SD = .24). The therapist
appeared to adhere to the treatment manuals.
Child compliance with the treatment assessed whether the participant did the
home assignment, with codings ranging from 0 (not at all) to 2 (completely). If the
participant did the homework assignment two more ratings were required and assessed
how thoroughly and carefully the home assignment was done and whether the participant
seemed to understand the concepts.
In assessing child compliance, comparison between the therapist investigator and
the three coders together produced 75% agreement (n - 108) with Kappa = .44 (p < .000),
suggesting fair agreement. Examination of the agreement between the therapist
investigator and each of the coders suggest fair or poor agreement with all of them.
Comparison with coder 1 produced 78% agreement (n = 27) with Kappa = .56 (p < .001).
Comparison with coder 2 produced 64% agreement (n = 36) with Kappa = .37 (p < .004).
Comparison with coder 3 produced 85% agreement (n = 54) with Kappa = .57 (p < .000).
For child adherence, the average therapist investigator's adherence rating (n =
208) was .31 (SD = .44) and the average coders' adherence rating (n = 34) was .23 (SD =
.35). Coder l's average (n = 9) was .39 (SD - .47), coder 2's average (n — 12) was .39
(SD = .43), coder 3's average (n = 18) was .15 (SD = .32). Based on the therapist
investigator's and coders' report, it appeared that the participants adhered to the treatment
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between 33% and 75% of the sessions and when they did, their homework was done
thoroughly and carefully between 11% and 33% of the times.
Caregiver compliance with the treatment assessed whether the caregiver
implemented the caregiver skills worked on. Codings ranged from 0 (not implement) to
either 1 or 3 (implement the skill: 1 when one skill was targeted and 3 when three skills
were targeted). Also, it assessed how invested the caregiver appeared during the treatment
session ranging from 0 (not at all) to 4 (very invested).
In assessing caregiver compliance with the treatment, comparison between the
therapist investigator and the three coders together (n = 32) produced 94% agreement
with Kappa = .89 (p < .000), suggesting very good agreement. Examination of the
agreement between the therapist investigator and each of the coders suggested very good
to excellent agreement with all of them. Comparison with coder 1 produced 100%
agreement (n = 4) with Kappa = 1.00 (p < .046). Comparison with coder 2 produced 93%
agreement (n = 14) with Kappa = .88 (p < .000). Comparison with coder 3 produced 93%
agreement (n = 14) with Kappa = .89 (p < .000).
For caregiver adherence, the therapist investigator's average (n = 64) was .97 (SD
= .11) and the coders' average (n = 12) was .98 (SD = .06). Coder 1 's average (n = 2) was
1.00 (SD = .00), coder 2's average (n = 5) was .96 (SD = .09), and coder 3's average (n =
7) was .97 (SD = .08). Thus, at least in terms of their in-session expressions, it appeared
that the caregivers were very invested in the treatment and willing to support the child in
its implementation.

CHAPTER HI
RESULTS
Fourteen participants completed all assessment points and one participant
completed only pre-, mid-, and post-treatment assessments. Fourteen maternal caregivers
and five paternal caregivers participated in the treatment. Thirteen maternal caregivers
completed all assessment measures at all assessment points. One maternal caregiver
completed assessment measures at pre-, mid-, and post-treatment except for the PSI and
the CSQ at post-treatment. For the PSI, mid-treatment data points were carried forward to
post-treatment. For this maternal caregiver, results were also not available at one-month
follow-up. All five participating paternal caregivers completed all assessment measures at
all assessment points. However, their low number limits the statistical analysis of their
data. As such, the statistical analyses of paternal reports are included in the tables but the
p values are not interpreted in the text.
Group Changes
Depressive Symptoms
Change on measures assessing depression was reported by both the participants
and the therapist investigator, with the same pattern of change occurring throughout the
treatment. The average pre-treatment score of 17.73 on the CDI was well into the clinical
range, decreased to 10.07 at mid-treatment, and continued decreasing to a post-treatment
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average score of 6. The Friedman test documents the statistical significance of change on
the CDI, X2(15) = 27.56, p < .000 (see Table 3). This change was maintained at onemonth follow-up with a score of 5.93 (see Figure 1) with no statistically significant
change between post-treatment and follow-up (see Table 4). Follow-up comparisons
using Wilcoxon signed-ranks test revealed statistically significant change from pre- to
mid-treatment, z (15) = -3.31, p < .001, and from mid- to post-treatment, z (15) = -2.76,
p < .006.
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Figure 1. Group change on the Children's Depression Inventory (CDI) from pretreatment to one-month follow-up,
Similar improvement was also apparent on the CDRS-R, where the pre-treatment
average of 47.4, which indicates depressive disorder, decreased to an average of 30.2 at
mid-treatment and 25.07 at post-treatment, a score indicating that depressive disorder is
unlikely. The Friedman test indicated statistically significant change on the CDRSR, x2(15) = 26.53,/? < .000 (see Table 3). The improvement on the CDRS-R was also
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5.36
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23.15
2.00

1.02
4.15
21.06
2.80

2.19

18.66
5.20
4.67
5.51
1.46

16.18
17.37

29.53
22.27
0.78
17.59
0.62
18.50
1.20

27.56
26.53

Friedman test

<.000
<.368

<.601
<.126
<.000
<.247

<.334

<.000
<.074
<.097
<.064
<.482

<.000
<.000

<.000
<000
<.678
<.000
<.735
<.000
<.549

<.000
<.000

P value

Note. CDI = Children's Depression Inventory; CDRS-R = Children Depression Rating Scale-Revised; CGAS = Children's Global Assessment Scale; SDQ
= Strengths and Difficulties Questionnaire; SRCS = Self Report Coping Scale; ATQ = Automatic Thoughts Questionnaire; CTI = Cognitive triad
inventory; CCSUS = Child Coping Skills Under Stress; SRCS = Self Report Coping Scale; SRAL = Self Report Activation Level; PCRQ = Parent Child
Relationship Questionnaire. Total number of participants =15. Total number of maternal caregivers = 14. Total number of paternal caregivers = 5.

Depressive symptoms
CDI child
CDRS-R therapist investigator
Global psychological functioning
CGAS therapist investigator
SDQ GENERAL maternal caregiver
SDQ GENERAL paternal caregiver
SDQ predict any diagnosis - maternal caregiver
SDQ predict any diagnosis - paternal caregiver
SDQ - Impact maternal caregiver
SDQ - Impact paternal caregiver
Negative thinking
ATQ child
CTI child
Coping Skills
CCSUS maternal caregiver
SRCS child
SRCS - Avoidance child
SRCS - Internalizing child
SRCS - Approach child
Activation level
SRAL Total
Caregiver-child relations
PCRQ child towards mother
PCRQ child towards father
PCRQ maternal caregiver
PCRQ paternal caregiver
Caregivers' stress level
PSI-SF maternal caregiver
PSI-SF paternal caregiver

Mid-treatment

Pre-treatment

Table 3
Pre-, Mid-, and Post-Treatment Scores and Friedman Tests for Participants and Caregivers

Follow-•up

Wilcoxon test
M
SD
M
SD
P value
Outcome Variable
Depressive symptoms
CDI child
6.00
7.94
5.93
8.78
-0.18
<.856
CDRS-R therapist investigator
7.09
24.14
7.97
-0.18
<.858
25.07
Global psychological functioning
CGAS therapist investigator
78.13
9.44
81.79
9.75
-2.28
<.023
SDQ GENERAL maternal caregiver
7.86
3.10
7.15
3.36
-0.35
<.725
SDQ GENERAL paternal caregiver
16.20
7.05
7.60
3.21
-1.76
<.078
SDQ predict any diagnosis - maternal caregiver
1.07
0.27
1.08
0.28
0.00
<1.00
SDQ predict any diagnosis - paternal caregiver
2.20
1.10
1.40
0.55
-1.60
<.109
SDQ - Impact maternal caregiver
1.21
1.81
0.46
0.97
-1.98
<.048
SDQ - Impact paternal caregiver
2.40
2.61
0.20
0.45
-1.63
<.102
Negative thinking
ATQ child
13.07
5.36
14.29
7.70
-0.42
<.673
CTI child
16.87
2.85
16.93
3.36
-0.48
<.631
Coping Skills
CCSUS maternal caregiver
0.74
0.22
0.76
0.67
-0.85
<.398
SRCS child
22.63
121.36
22.11
-0.18
<.861
118.67
SRCS - Avoidance child
40.07
14.85
37.00
10.88
-1.26
<.209
SRCS - Internalizing child
12.43
5.46
-0.39
<.699
13.47
7.61
SRCS - Approach child
16.53
50.36
16.67
-0.75
<.451
50.67
Activation level
SRAL Total
6.75
39.21
6.59
-0.36
<.720
38.93
Caregiver-child relations
PCRQ child towards mother
147.14
21.98
149.15
21.64
-0.67
<.505
PCRQ child towards father
143.86
17.68
141.86
20.86
-0.44
<.660
PCRQ maternal caregiver
233.00
22.27
235.46
22.60
-0.63
<.530
PCRQ paternal caregiver
217.40
5.13
219.20
12.21
-0.41
<.686
Caregivers' stress level
PSI-SF maternal caregiver
63.29
16.40
54.62
16.68
-1.97
<.049
PSI-SF paternal caregiver
77.20
10.35
63.60
16.82
-1.75
<.080
Note. CDI = Children's Depression Inventory; CDRS-R = Children Depression Rating Scale-Revised; CGAS = Children's Global Assessment Scale;
SDQ = Strengths and Difficulties Questionnaire; SRCS = Self Report Coping Scale; ATQ = Automatic Thoughts Questionnaire; CTI = Cognitive triad
inventory; CCSUS = Child Coping Skills Under Stress; SRCS = Self Report Coping Scale; SRAL = Self Report Activation Level; PCRQ = Parent Child
Relationship Questionnaire. Total number of participants = 15. Total number of maternal caregivers = 14. Total number of paternal caregivers = 5.
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maintained at one-month follow-up with an average of 24.14 (see Figure 2), which was
not statistically significantly different than the post-treatment average (see Table 4).
Follow-up comparisons using Wilcoxon signed-ranks test revealed statistically
significant change from pre- to mid-treatment, z (15) = -3.41, p < .001, and from mid- to
post-treatment, z (15) = -2.68,/? < .007.
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Figure 2. Group change on the Children's Depression Rating Scale - Revised (CDRS-R)
from pre-treatment to one-month follow-up.
Global Psychological Functioning
Assessment of the child's psychological functioning according to the C-GAS
revealed statistically significant change during the treatment course. The average pretreatment C-GAS of 55.53, which indicated variable functioning with sporadic
difficulties, improved to 70.2 at mid-treatment, which indicated some difficulty in a
single area but generally functioning pretty well, and 78.13 at post-treatment, which
indicated only a slight impairment in functioning. The change was statistically significant,
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%2(15) = 29.53, p < .000 (see Table 3). The score at post-treatment continued to improve
at one-month follow-up to 81.79, which indicates good functioning, z (14) = -2.28,p <
.023 (see Table 4).
Improvement was also reported by the caregivers. On the SDQ-P maternal
caregivers reported statistically significant improvement from an average of 17.93 at pretreatment, which was within the abnormal range, to 13 at mid-treatment and 7.86 at posttreatment, which was well into the normal range, X2(14) = 22.27, p < .000 (see Table 3).
Improvement was maintained at one-month follow-up (M= 7.15; see Figure 3) with no
statistically significant change (see Table 4). Paternal caregivers' report of their children's
psychosocial functioning also moved in the therapeutic direction; however, with a
different pattern of change. The means start in the abnormal range (M= 17.8) at pretreatment, move to the borderline range by mid-treatment (M= 13.6), but then increase at
post-treatment (M= 16.2; see Table 3), followed by a decline to the normal range at
follow-up (M= 7.6; see Table 4 and Figure 3). Looking at the individual reports of the
paternal caregivers (see Figure 4), it is evident that the increase from mid- to posttreatment was influenced by reports of two paternal caregivers (8 and 11), who reported
deterioration from mid- to post-treatment, while the other three paternal caregivers
reported either continual improvement (1 and 7) or maintenance (3) of results from midto post-treatment.
Based on maternal SDQ-P reports, the estimated likelihood that the children
warranted a diagnosis according to the DSM classification, moved from an average of
2.36 at pre-treatment, which was in the "medium risk" range, to an average of 1.86 at
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Figure 3. Group change on the Strengths and Difficulties Questionnaire (SDQ) from pretreatment to one-month follow-up reported by maternal and paternal caregivers
(SDQ-P) and by teachers (SDQ-T).
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Figure 4. Individual changes on the Strengths and Difficulties Questionnaire (SDQ-P)
from pre-treatment to one-month follow-up reported by paternal caregivers.
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mid-treatment and to the "low risk" range at post-treatment with a score of 1.07 (see
Table 3), which was maintained at one-month follow-up (M= 1.08; see Table 4). This
change was statistically significant, %2(14) = 17.59,/? < .000 from pre- to mid- and to
post-treatment, but not from post-treatment to follow-up. Paternal caregivers' report,
again, had a different pattern indicating improvement from the "medium risk" range at
pre-treatment (M= 2.2) to mid-treatment {M- 1.8) with worsening at post-treatment (M
= 2.2; see Table 3) and then showing improvement at one-month follow-up (M = 1.4) to
the "low risk" range (see Table 4). Again, there were individual differences in the
paternal caregivers' reports with the same two (8 and 11) reporting worsening of their
children's condition from mid- to post-treatment, when the same pattern was not reported
by the other three paternal caregivers.
The average report of maternal caregivers on the SDQ-P at pre-treatment
indicated that the difficulties their children experienced had a very negative impact on the
participants' lives (M= 5.29). This score improved at mid-treatment to 3.5 and continued
improving at post-treatment (to the borderline range) with an average of 1.21, %2(14) =
18.50,/? < .000 (see Table 3). This change continued at one-month follow-up where the
average of .46 now fell in the normal range. The change from post-treatment to onemonth follow-up was statistically significant, z (13) = -1.98,/? < .048 (see Table 4).
Paternal caregivers' report of the impact of the difficulties on their children's life was
similar to the paternal caregivers' report pattern indicated above and evinced change in
the therapeutic direction from a score of 4.4 (abnormal range) at pre-treatment to 2.4 at
post-treatment, which actually somewhat worsened from the mid-treatment average of 2
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(see Table 3), but continued to improve at one-month follow-up to .2, which is within the
normal range (see Table 4). However, as was already reported above, there were
individual differences in the paternal caregivers' reports, with three of the five paternal
caregivers (3, 8 and 11) reporting worsening of their children from mid- to post-treatment
and the other two paternal caregivers (1 and 7) reporting improvement from mid- to posttreatment.
The teachers also reported improvement in the participants' functioning. All
teachers completed the SDQ-T at pre-, mid-, and post-treatment. However, at one-month
follow-up only teachers of nine participants completed the SDQ-T. As can be seen in
Table 5, the teachers reported improvement in the participants' functioning from an
average pre-treatment in the abnormal range (M= 16.74) to mid-treatment (M= 11.68)
and post-treatment (M= 10) scores that are in the normal range, %2(15) = 8.83,/? < .012
(see Table 5 and Figure 3). Results at post-treatment were not statistically different from
the available one-month follow-up data {M= 10.39; see data in Table 6). Controlling for
problems of averaging the scores when more than one teacher completed the SDQ-T for a
child also showed similar results. SDQ-T estimates of the likelihood of warranting any
diagnosis according to the DSM classification, moved from an average of 2.44 at pretreatment, which was in the "medium risk" range to an average of 1.63 at mid-treatment
and to an average of 1.29 at post-treatment, which was in the 'low risk' range, %2(15) =
15.17,/? < .001 (see Table 5). No change occurred from post-treatment to follow-up (M=
1.39; see Table 6). Similar results were obtained using the alternative SDQ-T analyses
due to having multiple teachers' ratings of some children. Teachers' report on the SDQ-T
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at pre-treatment indicated that the difficulties the participants experienced had a negative
impact on the participants' lives (M = 3.48). This score improved at mid-treatment to an
average of 1.98 and at post-treatment to an average of 1.43, both in the borderline range,
X2(15) = 14.37,/? < .001 (see Table 5). This change continued at one-month follow-up to
the normal range with an average of 1.06 (see Table 6). Controlling for problems of
averaging the scores when more than one teacher completed the SDQ-T also showed
similar results.
Negative Thinking
Both measurements assessing negative thinking showed statistically significant
change. Pre-treatment ATQ-SF scores moved from an average of 20.53, which was above
the clinical cutoff, to 16.87 at mid-treatment and 13.07 at post-treatment, a score within
the normal range and that represents statistically significant change, %2(15) = 16.18,/? <
.000 (see Table 3). The post-treatment score was maintained at one-month follow-up (M
= 14.29; see Table 4 and Figure 5). Similarly, the CTI-C-SF evinced significant
improvement from a pre-treatment average of 13.67 to 16.27 at mid-treatment and 16.87
at post-treatment, %2(15) = 17.37,/? < .000 (see Table 3). This change was maintained at
one-month follow-up with a score of 16.93 (see Table 4 and Figure 6).
Coping Skills
Maternal caregivers reported statistically significant change in their children's
coping skills on the CCSUS. The average improved from .28 at pre-treatment to .54 at
mid-treatment, .74 at post treatment (see Table 3), and .76 at one-month follow-up (see
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Figure 5. Group change on the Automatic Thoughts Questionnaire - Short Form (ATQSF) from pre-treatment to one-month follow-up.
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Figure 6. Group change on the Cognitive Triad Inventory - Short Form (CTI-C-SF) from
pre-treatment to one-month follow-up.
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Table 4), %2(14) = 18.66,/? < .000. In addition, there was no statistically significant
change from post-treatment to follow-up.
Participants' report also indicated changes in the therapeutic direction in their
coping skills; however, the changes were not statistically significant (see Tables 3 and 4).
On the SRCS, the participants reported improvement from a score of 109.53 at pretreatment to 117.13 at mid-treatment, 118.67 at post-treatment, X2(15) = 5.20, p < .074.
The improvement continued to 121.36 at one-month follow-up. On the avoidance scale,
which includes "distancing," "internalizing," and "externalizing," they reported
improvement from 45.67 at pre-treatment, to 41.67 at mid-treatment, and 40.07 at posttreatment, 5C2(15) = 4.67, p < .097. The improvement continued at one-month follow-up
with an average of 37. Looking specifically at the internalizing subscale, the participants
reported improvement in the level of internalizing on the SRCS from an average of 18.47
at pre-treatment to 15 at mid-treatment and 13.47 at post-treatment, %2(15) = 5.51,p <
.064. The improvement continued at one-month follow-up with an average of 12.43. On
the approach subscale, which includes "problem solving" and "seeking of social support,"
improvement was reported from pre-treatment (M- 47.2), to mid-treatment (M= 50.8),
which was maintained at post-treatment (M= 50.67), %2 (15) = 1.46,p < .482.
Improvement was maintained at one-month follow-up with an average of 50.36.
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Activation Level
Participants reported no change in their activity level from pre-treatment (M=
37.47) to post-treatment (M= 38.93; see Table 3), %2(15) = 2.19, p < .334. This generally
high activity level was also apparent at one-month follow-up (M= 39.21; see Table 4).
School Grades
Although the teachers reported improvement in the participants' functioning, they
did not report improvement in the participants' grades on the Academic Functioning
Record Form. The average of the grades went from a pre-treatment mean of 2.63 (SD .76) to a mid-treatment mean of 2.97 (SD = .65) and post-treatment mean of 2.66 (SD =
.85), %2(13) = 4.38,/? < .112 (see Table 5). Grades slightly increased at one-month follow
up to a mean of 2.85 (SD = .67), but the change was not statistically significant (see Table
6). However, it is important to notice that there were large differences between the
participants.
Caregiver Child Relations
The participants did not report change in their relationships with both their
maternal caregivers and paternal caregivers on the PCRQ-C-SF, x2(15) = 1.02, p < .601,
and %2(15) = 4.15,p < .126, respectively (see Table 3). On the other hand, maternal
caregivers reported statistically significant change in their relationships with their
children. They reported an average of 208.29 at pre-treatment that improved throughout
the treatment to 223.21 at mid-treatment, and 233 at post-treatment, %2(1A) = 21.06,p <
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.000 (see Table 3). The change was maintained at follow-up with a score of 235.46 that
was not statistically significantly different from that of the post-treatment (see Table 4).
Paternal caregivers' report also indicated change in the therapeutic direction in their
relationships with their children from a score of 196.6 at pre-treatment, to 215.4 at midtreatment, 217.4 at post-treatment (see Table 3), and 219.2 at follow-up (see Table 4).
Caregivers' Stress Level
Maternal caregivers reported statistically significant change in their stress level on
the PSI-SF, from pre-treatment (M= 82.36) to mid-treatment (M= 73.14) and posttreatment (A£= 63.29), %2(14) = 23.15,/? < .000 (see Table 3). The decease in stress level
continued at one-month follow-up (M= 54.62; see Table 4 and Figure 7) and was
statistically significant, z (13) = -1.97,/? < .049. Paternal caregivers reported significant
decrease in their stress level from an average of 89.2 at pre-treatment, to 76.8 at midtreatment, 77.2 at post-treatment (see Table 3), and 63.6 at one-month follow-up (see
Table 4 and Figure 7).
Caregivers' Satisfaction with the Treatment
Caregivers reported strong treatment satisfaction on the CSQ that was
administered at post-treatment. The mean was 3.94 (SD = .11) for maternal caregiver and
4 for paternal caregiver.
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Figure 7. Group change on the Parenting Stress Inventory - Short Form (PSI-SF) from
pre-treatment to one-month follow-up for maternal and paternal caregivers.
Benchmarking of Psychotherapy Studies
To benchmark the current findings against existing psychological treatment
studies, four randomized clinical trials with similar characteristics were identified (see
Appendix I). The average age in these studies was 10.16 for the CBT groups and 9.88 for
the control groups (see Table 7). The female percentage was 47 and 46 in the CBT and
the control groups, respectively, and the Caucasian percentage was 88 and 78 in the CBT
and control groups, respectively (see Table 7). For the CBT groups, the CDI benchmark
was 19.26 and 9.74 at pre- and post-treatment, respectively, and for the control groups,
the CDI benchmark was 19.2 and 15.67 at pre- and post-treatment, respectively. For the
follow-up data, the CDI benchmarks for the CBT and control groups, respectively, were
8.78 and 12.93 at 1- to 3-month, 6.63 and 12.75 at 4- to 6-month, and 5.77 and 10.25 at 7to 9-month. For the studies used, the CDRS-R benchmark for the CBT groups was 38.66
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Note. PASCET = Primary and Secondary Control Enhancement Training; C-CRET = Caregiver-Child Relationship Enhancement
Training; Pre = Pre Treatment; Post = Post Treatment; FU = Follow Up; CDI = children's Depression Inventory; CDRS-R =
Children's Depression Rating Scale - Revised; aData is from De Cuyper et al. (2004) and Weisz et al. (1997) bLiddle & Spence
(1990) and Stark et al. (1991); cDe Cuyper et al. (2004); dWeisz et al. (1997); eStark et al. (1991) and Weisz et al. (1997); fStark et al.
(1991); gWeiszetal. (1997).
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and 26.75 at pre- and post-treatment, respectively, and for the control groups, the CDRSR benchmark was 34.36 and 31.55 at pre- and post-treatment, respectively. For the
follow-up data, the CDRS-R benchmarks for the CBT and control groups, respectively,
were 22.49 and 22.6 at 1- to 3-month, and 28.08 and 28.59 at 7- to 9-month.
Looking at the pre-treatment CDI data, the PASCET+C-CRET group started at
similar average scores (M= 17.73) to the CBT (M= 19.26) and control (M= 19.2)
benchmark groups (see Table 7 and Figure 8). In addition, all groups were well above the
CDI normative average of 9.09 (Smucker et al, 1986). At post-treatment the
PASCET+C-CRET group was well below the CDI normative average (M= 6), while the
CBT groups were just reaching the average (M= 9.74) and the control groups were still in
the abnormal range (M= 15.67). At 1- to 3-month follow-up the PASCET+C-CRET
group maintained the results from post-treatment (M= 5.93) while the CBT benchmark
group (Liddle & Spence, 1990; Stark et al., 1987) improved to just below the average (M
= 8.78) and the control group (Liddle & Spence, 1990; Stark et al., 1987), while
improved, was still elevated (M= 12.93). At 4- to 6-month follow-up the CDI benchmark
(from De Cuyper et al., 2004) for the CBT group (M= 6.63) was close to the PACET+CCRET group's average CDI at 1- to 3-month follow-up. However, De Cuyper et al.'s
sample (2004) began treatment with a much lower CDI average compared to our group
(see Appendix I). At 7- to 9-month follow-up the CDI benchmark (taken exclusively from
Weisz et al., 1997) for the CBT group (M= 5.77) was similar to the 1- to 3-month followup CDI in the PASCET + C-CRET group. In addition, by this time, the control group
showed improvement that approached the normative CDI average (M= 10.25).
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Figure 8. Comparison of PASCET + C-CRET group's Children's Depression Inventory
(CDI) mean to CBT and control groups' CDI benchmark at pre-treatment (PreTx), post-treatment (Post-Tx), 1-3 month follow-up (1-3 mo. FU), 4-6 month
follow-up (4-6 mo. FU), and 7-9 month follow-up (7-9 mo. FU).
Within-group effect sizes on the CDI suggest that for the PASCET+C-CRET
group changes were large (g = 1.56), and at least as good as the effect size for the CBT
benchmark group (g - 1.49), and clearly exceeding the effect size in the control
benchmark group (g = .49). In summary, the PASCET+C-CRET group compares very
favorably with benchmarks from the literature.
The trends observed in the CDRS-R data are generally consistent with the CDI
data (see Table 7 and Figure 9). The pre-treatment CDRS-R average was higher for the
PASCET+C-CRET group (M= 47.4) compared to the CDRS-R benchmark for CBT
groups (M= 38.66) and the control group (M= 34.36). Both the PASCET+C-CRET

group (M= 25.07) and the CBT groups (M= 26.75) declined to the non-depressed range
at post-treatment. The total amount of CDRS-R change was almost twice as large for the
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Figure 9. Comparison of PASCET + C-CRET group's Children's Depression Rating
Scale-Revised (CDRS-R) mean to CBT and control groups' CDRS-R
benchmark at pre-treatment (Pre-Tx), post-treatment (Post-Tx), 1-3 month
follow-up (1-3 mo. FU), and 7-9 month follow-up (7-9 mo. FU).
PASCET+C-CRET group (difference score = 22.33) compared to the CBT benchmark
(difference score = 11.91) and almost eight times larger than control benchmark
(difference score = 2.81). At 1- to 3-month follow-up the results were maintained for both
the PASCET+C-CRET group (M= 24.14) and the CBT benchmark (taken exclusively
from the Stark et al., 1987; M= 22.49). The control group also had a significant
improvement (M= 22.6) to a point that equaled the PASCET+C-CRET group and the
CBT benchmark. At 7- to 9-month follow-up, both benchmarked CDRS-R averages
(taken from Weisz et al., 1997) were also similar (CBT, M= 28.08 and control group, M
= 28.59).
Within group effect size on the CDRS-R suggests that for the PASCET+C-CRET
group changes were large (g = 2.95), and clearly exceeded the effect sizes for both the
CBT benchmark group (g = 1.24) and the control benchmark group (g = .33). In total, the
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benchmarking data suggest that PASCET+C-CRET moderately outperformed CBT
treatments in other studies and appeared markedly superior to control conditions.

Benchmarking of Medication Studies
In addition to benchmarking the current results against relevant psychosocial
treatments, the findings were also compared to two pharmacology studies (which were
critical to the FDA's approval of fluoxetine for youth depression; Emslie et al., 2002;
Emslie et al., 1997; see Appendix J). Both of these randomized clinical trials had several
similar characteristics to the PASCET+C-CRET group. The average age in the fluoxetine
and the placebo benchmarks was 12.45 and 12.6, respectively (see Table 8), which is
slightly higher but still comparable to the current sample. The percentage of the sample
that was Caucasian (81% in both fluoxetine and placebo groups) was similar. However,
there appears to be a greater percentage of females in the PASCET+C-CRET group
(67%) than the fluoxetine (48%) and placebo (48%) groups. In addition, the medication
trials had significantly larger samples (78.5 in both groups) than in the PASCET+CCRET group.
For the fluoxetine groups, the CDRS-R benchmark was 57.8 and 36.75 at pre- and
post- treatment, respectively, and for the placebo groups, the CDRS-R benchmark was
56.35 and 43.65 at pre- and post-treatment, respectively. Looking at the CDRS-S
benchmarks, the PASCET+C-CRET group started at somewhat lower pre-treatment
average (M= 47.4) than the fluoxetine and the placebo groups (see Table 8 and Figure
10). However, the overall amount of change was comparable. As described in the

M
15/14 FU
10.27
67
87
47.40
25.07
8.04
7.09

2.02

SD

M
78.50
12.45
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15.25
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Note. PASCET = Primary and secondary Control Enhancement Training; C-CRET = Caregiver-Child relationship Enhancement
training, Pre = Pre Treatment; Post = Post Treatment; CDRS-R = Child Depression Rating Scale - Revised.

Outcome Variable
n
Age
% female
% Caucasian
Pre CDRS-R
Post CDRS-R

PASCET+C-CRET

Comparison ofPASCET+ C-CRET Group to Fluoxetine and Placebo Benchmark Groups

Table 8
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60.00
55.00
50.00
45.00

- • — Fluoxetine
- • — Placebo
- A — PASCET+C-CRET
CDRS-R non-depressed

40.00
35.00
30.00
25.00
20.00
15.00

Pretreatment

Post-Treatment

Figure 10. Comparison of PASCET + C-CRET group's Children's Depression Rating
Scale-Revised (CDRS-R) mean to fluoxetine and placebo groups' CDRS-R
benchmarks at pre-treatment and post-treatment.
preceding section, the CDRS-R change in PASCET+C-CRET was 22.33, which was
similar to that in the fluoxetine group (difference score = 21.05). In addition, while the
pill placebo group also improved from pre- to post-treatment (difference score = 12.7),
the PASCET+C-CRET group improvement was substantially larger. Thus, based on the
existing benchmarks, PASCET+C-CRET appeared to compare favorably to
pharmacotherapy and to outperform a pill placebo.
Moderators of Change
Moderator analyses attempt to address the question of what works for whom. That
is, they attempt to determine what, if any, pre-treatment variables predict response to
treatment. In the current analyses the following potential moderators were examined: age
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of the participants, gender, income, past use of psychiatric medications, participants' pretreatment negative thoughts, coping skills, psychosocial functioning, caregiver-child
relations, maternal caregivers' stress level, child compliance with the treatment, and
caregiver compliance with the treatment. To examine their influence, pre- to posttreatment residualized change scores were calculated for the CDI and the CDRS-R. Next,
correlations between the potential moderators and assessment of depression change were
calculated. These analyses found that age was a moderator of change in depressive
symptoms on the CDI (r = .69, p < .004) but not the CDRS-R (r = .37, p < . 18). This
correlation suggests that the older the participants, the more change they self-reported in
their depressive symptoms. None of the other demographic variables assessed was found
as a moderator of change of depressive symptoms with correlations ranging from r = -.08
tor = -.31(p = .774-.258).
Pre-treatment negative thoughts about the world and the future (CTI-C-SF) was a
moderator of change on the CDRS-R, r = -.55,/? < .034. This correlation suggests that the
more negative thoughts about the world and the future the participants reported at pretreatment, the more change they reported in depressive symptoms. This result, however,
was not replicated on the CDI (r = -. 19, p < .493). No other measures were found as
moderators of change in depressive symptoms with correlations ranging from -.01 to .39
(p = .975 to .159).
Within Treatment Predictors of Change
To examine within treatment predictors of change, analyses were conducted to
assess whether changes in the first part of the treatment predicted change in depressive
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symptoms in the second part of the treatment on the CDI and CDRS-R. To do so, pre- to
mid-treatment residualized change scores on the SDQ-P of maternal caregivers, ATQ-SF,
CTI-C-SF, SRCS, CCSUS, SRAL, PCRQ-C towards both caregivers, PCRQ-P of
maternal caregivers, and PSI-SF, were calculated. These were then correlated with midto post-treatment residualized change scores on the CDI and CDRS-R. The only trend
that was observed was between negative self-thoughts (ATQ-SF) and depressive
symptoms on the CDRS-R, r = .49, p < .066, indicating that improvement in the first part
of the treatment in negative self-thoughts predicted better improvement in depressive
symptoms in the second part of the treatment. This result was not replicated on the CDI,
r = .28,p < .321. The calculations on the remaining variables ranged from .00 to .35 (p =
.991 to .197).

CHAPTER IV
DISCUSSION
The study provides evidence supporting the efficacy of a combined treatment for
youth depression, which includes individual CBT using the PASCET manual with
accompanying caregiver-child sessions focusing on the use of positive parenting
practices.
The group in the current study demonstrated significant changes both in
depressive symptoms and also in associated symptoms, including negative thinking and
psychosocial functioning. Changes were noted by all reporters—the participants, the
caregivers, the teachers, and the therapist investigator. In addition, the caregivers reported
a significant decrease in their stress level and significant improvement in their
relationship with their children. The exception was caregiver-child relationships from the
perspective of the child, which showed no change. The consumer satisfaction data
indicate that the caregivers were highly satisfied with the treatment they received.
The study adds to existing data from previous studies documenting the efficacy of
CBT for reducing depressive symptoms in children. Most of the previous studies with this
population were conducted in a group format. The format of the current treatment was
individual. As such, the current results provide promising data about the (expected)
generalizability of effects when CBT is offered in this modality. Comparison of the
combined treatment with a benchmark derived from existing psychotherapy studies
77
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established the current treatment as at least as good as the other CBT treatments and
appeared markedly superior to control conditions. Assessment of the combined treatment
with a benchmark from the pharmacotherapy studies, which were influential in fluoxetine
achieving FDA approval for use with depressed youth, revealed that it also compares
favorably to pharmacotherapy and appears to outperform a pill placebo.
The combined protocol used in this study reflects an attempt to incorporate
recommendations made in and following from previous intervention studies. The current
study integrated recommendations made by Weisz et al. (2006), including increasing the
treatment dose and adding the caregiver component to create more multi-component
packages with the use of new methods. Addition of the caregivers also follows from
knowledge of the psychopathology literature and its relationship to the existing
intervention outcome literature for depressed youth. These two literatures are currently
somewhat disconnected in the sense that despite a large number of studies linking family
context and relations to child depression (e.g., Hammen, 1991), and the consistent
recommendation to more fully incorporate caregivers into the treatment of depressed
children (e.g., Lovejoy et al., 2000; Stark et al., 2001; Stark et al., 2000), only a very
small number studies incorporated caregivers to work on child-caregiver relations. For
instance, none of the psychosocial treatment studies used to establish our benchmark
included the caregivers for caregiver sessions and only two included them for assessment
(De Cuyper et al., 2004 and Stark et al., 1987). Thus, the current study provides
promising data regarding including the caregivers for caregiver training sessions not only
to increase their involvement and improve the outcome for the child, but also to reduce
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familial stress, improve the caregiver-child connection and relationships, and improve
parenting and family functioning (Sexson et al., 2001).
The current study demonstrates an attempt at increasing the ease of access to
effective professional clinical services for children by conducting the intervention at their
school. In all the benchmarked studies, the intervention was conducted in the child's
school but none included the caregivers in the intervention. A school setting may make it
more challenging to include caregivers than when caregivers are bringing the child to a
research clinic. However, this potential increased difficulty should not be seen as an
impossibility, as the school is often in relatively close proximity to the family residence
and families are often accustomed to coming to the school for meetings. Also, when
caregivers are not working, conducting the treatment at the schools provides an
opportunity to conduct the caregiver sessions during the school day when the children are
at school and there is no need for childcare services.
Fluoxetine (Prozac) is the only medication approved by the FDA for use to treat
depression in children age seven and older. This designation was earned in response to
studies demonstrating that fluoxetine was more effective than placebo for the treatment of
depressed youth (Emslie et al., 2002; Emslie et al., 1997). However, the FDA issued a
Black Box Warning in September 2004 for antidepressant drugs, indicating that they may
increase suicidality in a subset of pediatric cases (http://www.fda.gov). This warning
appears to have led to a significant decrease in the number of youth prescribed with
antidepressants (Nemeroff et al., 2007). Therefore, it is important to continue developing
treatments for depressed youth that are empirically-based and easily accessed.
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Many intervention studies for depressed youth fail to assess child functioning
from the perspective of primary caregivers and other adults who are routinely in contact
with the child. In addition, there are often discrepancies between caregiver, teacher, and
child reports regarding identified problem areas and the nature and extent of reported
improvement (Cantwell, Lewinsohn, Rohde, & Seeley, 1997; Kazdin, 1989; Yeh &
Weisz, 2001; Youngstrom, Loeber, & Stouthamer-Loeber, 2000). Given this backdrop, it
is significant that the teachers and both maternal and paternal caregivers reported
significant improvement in child psychological functioning. It may be that the
involvement of the caregivers in the treatment and the continual psychoeducation of the
caregivers about their child's treatment improved their awareness of their child's
psychological functioning and improvements in psychological function. The same process
may be applicable to teachers. By involving teachers in the assessment process and
applying learned skills to difficulties in the classroom when relevant, the therapy process
may have increased teachers' awareness of improvements and/or participants' efforts to
use skills acquired in the treatment. Additionally, given the design of the study, it is also
not possible to rule out the effects of repeated measurement in the context of an ongoing
treatment in which caregiver informants were also participants. The fact that caregivers
were both informants and participants may have produced a positive response bias.
Teacher reported changes also could be due to repeated measurement and awareness of
treatment participation, but this seems less likely for teachers than caregivers.
Despite the aforementioned possibilities, the most parsimonious explanation
appears to be that functioning improved during the treatment course. Clinician-
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administered, self-report, caregiver-report, and teacher-report data all generally suggested
significant improvement, which seems most likely to indicate that the treatment package
produced a real effect on child functioning. Unfortunately, given the uncontrolled design
of the study, reported changes cannot be conclusively attributed to the treatment.
It is also interesting to note that there were some areas where positive change was
not noted. Unfortunately, there were no significant changes in the participants' grades
throughout the treatment, which showed large individual differences between the
participants. In addition, perfect agreement was not obtained. While the caregivers
reported significant improvement in their relationships with their children, unfortunately,
the children did not report improvement in their relationships with their caregivers. There
may be a number of reasons for this difference. First, there may have been no changes in
the relationship, despite the caregivers report. That acknowledged, it may also be that the
children did not identify actual changes in their parents' behavior and/or their
relationships with them. Relatedly, it may be that it takes children longer to recognize
change in their parents' behavior, if such change exists. For instance, maybe children and
adolescents need discrimination training to learn to notice changes in their primary
caregivers' behavior. In addition, it was found in previous studies that there is poor
agreement between caregivers and children on family experiences. One of the reasons
suggested was that children are likely to focus on themselves while parents usually
compare the child with his/her siblings in the context of the home (Rutter & Sroufe,
2000). Only two of the seven caregiver sessions actually included the child so maybe the
child did not notice their caregivers' efforts. More sessions that include both the

82
caregivers and the children could provide the children with opportunities to notice their
caregivers' efforts and the changes in the caregivers' behavior.
Negative thinking is a theoretically targeted area for change in CBT protocols.
However, the necessity of the cognitive change techniques in producing cognitive change
has been a subject of debate (Ilardi & Craighead, 1994; Tang & DeRubeis, 1999). In the
present study both measures of depressotypic thinking showed significant improvement.
Even though depressotypic thinking was targeted in the second part of the treatment,
improvement was also reported in the first part of the treatment. That is, 81% of the CTI
improvement (negative thoughts about the world and future) and 49% of the ATQ
improvement (negative thoughts about the self) occurred from pre- to mid-treatment. It
seems plausible that by increasing positive activities and time spent in activities between
the caregiver and the child, negative thoughts decreased. Ongoing change in negative
self-thoughts in the second half of treatment may have been further encouraged by the
interventions targeting negative self-thought. However, the change in the second part of
the treatment may have simply been a continuation of that which started during the first
half owing nothing to the skills taught during the second half. Support for this latter
suggestion is inferred from the significant trend wherein ATQ improvement from pre- to
mid-treatment predicted depression change from mid- to post-treatment on the CDI. With
that, it was found that the more negative thoughts about the world and future the
participants reported at pre-treatment, the more change in depressive symptoms they
reported on the CDRS-R. This is supportive of an intervention targeting negative
thoughts making it especially efficacious for those high in that target behavior. Thus,
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much work remains to be done to determine the contribution of cognitive techniques and
cognitive change in the treatment process.
A potential alternative to cognitive therapy is behavioral activation. The first
portion of the current treatment involved activation (primary control) strategies and the
majority of depression symptom change was observed in the first part of treatment. This
supports the possibility that activating the child and changing the reaction to the external
environment was the active ingredient. However, only small improvement was reported
regarding involvement in enjoyable and non-solitary activities. It is possible that the 4point Likert scale used in a measure that was developed specifically for the current study
was too crude and did not correctly represent the actual involvement of the participants in
the activities.
The current study found that the children's age was a moderator of change in
depressive symptoms on the CDI, with older participants reporting more improvement in
depressive symptoms. The PASCET manual is intended to target depressive symptoms in
children as young as eight. It may be that some of the skills may not be as effective with
younger children possibly because they are more difficult to learn and comprehend. These
data serve as a reminder of the importance of assessing the understanding level of young
children and their ability to implement components of CBT protocols. This finding also
suggests the potential importance of even further increasing involvement of the caregivers
in the treatment. The limited cognitive abilities of younger children may prevent them
from being able to fully generalize skills from the setting where they were acquired to
other environments. Therefore, caregivers' role may be critical in assisting them in
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generalizing these skills to the home. Also, it may suggest that there is a need to develop
treatments, especially for younger children, that more specifically target caregiver-child
relations and/or family functioning. However, in interpreting the moderating effect of age,
it is important to remember that all children improved during the intervention.
Limitations
The major limitation of the current study is the open clinical trial design, which
weakens the internal validity. That is, it cannot be concluded with complete confidence
that the changes observed were the product of the intervention. Moreover, because all the
children received the treatment, with no control group, it is hard to interpret whether the
current treatment is more effective than other treatments, placebo controls, or notreatment. Using the benchmarking strategy to compare our group to treatment and
control conditions in previous psychotherapy and medication trials with similar age
ranges, primary dependent variables, inclusion criteria, and treatment timelines, provides
some anchor points for evaluating outcome, but it is not a full substitute for a concurrent
control group. The open clinical trial design with benchmarking can be useful in what are
termed effectiveness studies, which place a greater emphasis on external validity and
determining how the intervention implemented in a new setting compares to results from
randomized clinical trials. The current study has features of research therapy (as defined
by Weisz & Weiss, 1989) including therapy that focuses primarily on a certain problem
and involves exclusive reliance on specific therapy techniques with a therapist that is
trained in these specific therapy techniques. However, the study also has some
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characteristics of effectiveness studies (as defined by Weisz & Weiss, 1989) including
most participants being referred to the treatment by the school counselors with most of
them displaying other problems in addition to depressive symptoms, like ADHD and
learning problems.
An additional limitation is the absence of blind assessment, especially of the
clinician-rated measure of depression (CDRS-R). To overcome this limitation, 19% of the
interviews were coded to ensure their reliability and found a very high correlation
between the interviewer (therapist investigator) and the coder. This is not a complete
remedy for lack of blind assessment because the mere presence of the therapist
investigator could have altered responding. However, the results from the coder suggest
that the therapist investigator was accurately rating what was reported by the participants.
Other limitations in the present study include repeated testing which may have
increased the probability that the participants learned the "correct" answers, presence of
independent events that happened during the treatment and may have influenced the
results, maturation and development of the participants during the treatment that may
have influenced the results, and statistical regression to the mean.
Future Direction
The current study provides preliminary data about the efficacy of a combined
treatment of individual CBT plus caregiver training sessions. Future studies should
include a larger number of participants, which can increase diversity and allow more
generalizability of the results. It is also important to include more stringent control
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conditions. This could be done by incorporating a control group or an additional
treatment comparison group in a randomized clinical trial format to assess whether the
current treatment is better that other treatments and/or no treatment. Another approach
would be to use more rigorous single-participant designs. A multiple baseline design
could further protect internal validity and an ABC versus ACB design could explore the
relationship between early change and the treatment techniques used.
It is not clear whether the caregiver sessions had a direct positive influence on the
depression level or the caregiver-child relationships. It is possible that by improving the
depressive symptoms of the children, the caregiver-child relationships indirectly
improved. Future studies could include comparisons between two groups, one receiving
only individual CBT and one receiving CBT plus caregiver sessions or one receiving
CBT plus caregiver sessions and one receiving only caregiver sessions. Also, a
comparison between two groups in which each received different caregiver sessions
targeting different skills could be conducted to assess the influence of specific caregiver
skills on depressive symptoms.
Future studies could also assess multi-systemic approaches and target many
components that the empirical literature suggests contribute to the development and
maintenance of depressive symptoms in children. These treatments could focus on
decreasing family conflict and improving the interactions with greater inclusion of
siblings in family therapy. They could include several modules that would target
caregiver skills based on the specific needs of each family (as was done in the TADS
study; see Wells & Albano, 2005). In addition, such interventions could target family
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adversity (unemployment, poor housing) with the help of a social worker and might
include treatment for caregivers to address psychiatric disorders or psychosocial
functioning (via individual treatment, pharmacotherapy, and/or marital therapy)
depending of the specific needs of the caregivers. An additional layer for children might
also involve targeting learning problems through academic tutoring. Such a completely
systemic package might need to be reserved for the most severe cases and awaits an
experimental evaluation and economic assessment as has been done with multi-systemic
approaches in other areas (e.g., Saldana & Henggeler, 2006 for conduct disorder)
The benchmarked psychosocial treatments demonstrated improvement for the
control groups throughout the treatment and at follow-ups, which may follow the natural
course of depression. This trend further supports the importance of long follow-ups to
determine long-term effects of treatments compared to control groups. Also, looking at
the small number of participants in the psychosocial treatments and the large number of
participants in the pharmacotherapy studies, it is important to conduct larger scale
psychosocial studies.
In conclusion, the described study provided evidence supporting the efficacy of a
combined individual CBT with caregiver sessions for childhood depression. The study
adds to previous studies suggesting that CBT reduces depressive symptoms in children. It
also provides promising data about the potency of including caregiver/caregiver-child
sessions focusing on the use of positive parenting practices to increase the caregivers'
involvement and to potentially improve the caregiver-child relationships and the family
functioning. Comparison with existing studies establishes the treatment as at least as good
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as other cognitive behavioral andfluoxetinetreatments, and as superior to control and pill
placebo conditions. Finally, the current results suggest that implementing the treatment in
school settings is feasible, therefore increasing access to services to children and
caregivers. While the intervention in this study was provided at the school, the protocol
could be used in clinical practice as well.
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An Antisuicide Contract
Project title: Combined cognitive behavioral treatment plus caregiver sessions for childhood depression
Principallinvestigator. Scott T. Gaynor, Ph.D.

As part of my participation, I,

Co-Investigator. Dikla Eckshtain

, agree to the following:

1. I agree that one of my major goals is to live a long life with more pleasure and less unhappiness
than I have now.
2. I understand that wishing to die when I am very sad or upset stands in the way of achieving this
goal, and I therefore would like to overcome this tendency. I agree to use the treatment to learn
better ways to reduce sad feelings.
3.

Since I understand that this will take time, I agree in the meantime to refuse to act on urges to
injure myself between this day and until the treatment is over.

4. If at any time I should feel unable to resist a wish to hurt or kill myself, I agree to inform my
father/mother (or guardian) or the therapist,
5. The therapist,

.

, agrees to work with me during treatment to help me learn

constructive ways to cope with depression. In addition, she will attempt to help me as much as is
reasonable during hard times. However, she will not always be available, in which case I need to
inform my mother/father.
6. I agree to abide by this contract until the conclusion of the treatment or until it is openly
renegotiated with the therapist,

. In other words, if during the course of the treatment

I begin to feel like hurting or killing myself, I will discuss this with the therapist

Child's Signature

Date

Guardian's Signature

Date

Therapist's signature

Date

.
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Western Michigan University, Department of Psychology
Consent for Release of Information
Project Title: Combined cognitive behavioral treatment plus caregiver sessions for childhood Depression.
Principal investigator: Scott. T. Gaynor, Ph.D

I

Co-Investigator: Dikla Eckshtain, M.A.

(parent/legally authorized guardian) hereby authorize

(name of physician) to speak with Ms. Eckshtain regarding my child's medication management for social,
behavioral, emotional, and academic problems in order to coordinate care during his/her participation in
this project.

The use of the information is ONLY for the purpose of the current treatment.

Utilization of this form to release information is effective for the following period:
From

to

unless revoked by me in writing prior to the termination date.

My signature means that I have read this form and/or have had it read to me and explained in language that I
understand. I know what information is being disclosed.

Parent/Guardian signature:

Date:

Witness:

Date:
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Explanation Script for the Caregiver Given by the School Professional Via Phone
Introduction of self and review of his/her concerns derived from contact with the child. If appropriate in the
context of the discussion, then this study and the possibility of attending a meeting to get more information
and consider participation will be introduced.
"There is a project ongoing in the school right now that is being done by researchers in the
Psychology Department at Western Michigan University. The project is aimed at helping children
who are having a difficult time with: moodiness, sadness, irritability, lack of motivation, not
finding things as fun and rewarding as in the past, sleep problems, fatigue or loss of energy,
problems concentrating, making decisions, or solving problems, appetite changes, and feelings of
low self-esteem. These are symptoms of depression, but they can occur for a variety of reasons.
Your child does not have to be clinically depressed to participate in this project or to present with
all of the symptoms I just mentioned, but he/she does seem to demonstrate some significant
symptoms that appear to warrant further evaluation and intervention, either in this study or by
another mental health professional, including the school professionals.
The intervention is cognitive behavioral therapy, which involves helping to teach your child coping
skills to use in times of distress and to help alter his/her behavior or thinking and improve his/her
mood. The treatment is based on the most up-to-date information available on childhood
depression. The individual treatment includes 16 individual sessions between the therapist and
your child that focus on teaching coping skills. There are also 7 treatment meetings with the
caregiver to help encourage progress in the home environment and to actively involve the
caregiver in the intervention.
It is important to keep in mind that while CBT has a promising track record of use with children
and families, other types of treatment are available. Psychological practitioners in the community
often use family therapy where all members of the household participate. In addition, some
therapists use primarily supportive therapy or implement CBT (or other) skills in a less structured
fashion than would occur in a treatment study. In addition, some children with depressive
symptoms are taken to see a child psychiatrist to determine if antidepressant medication may be
helpful for them. If an alternative approach is more appealing to you, we can help refer you to
these types of services. In addition, it is also important to keep in mind that your child can receive
services from one of the school professionals, including the school counselor, school psychologist
or social worker. Whatever decision you make will be respected and we will do whatever we can
to facilitate your receiving your choice of treatment.
Is this something that you would be interested in setting up a meeting to learn more about and see
if you would like to participate?"
If the caregiver expresses interest, he/she will be invited for a meeting that will include the school
professional, the therapist investigator, the caregiver, and, for a portion of the meeting, the child. The
caregiver will be informed that this meeting will take about 60 minutes.
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Western Michigan University, Department of Psychology
Consent for Participation
Project Title: Combined cognitive behavioral treatment plus caregiver sessions for childhood depression
Principal investigator: Scott. T. Gaynor, Ph.D

Co-Investigator: Dikla Eckshtain, M.A.

Overview
You and your child have been invited to attend an assessment session today in order to consider
whether to participate in a treatment/research study entitled "Combined cognitive behavioral treatment plus
caregiver sessions for childhood depression." This project is conducted by Ms. Dikla Eckshtain, an
advanced graduate student pursuing her Ph.D. in Clinical Psychology at WMU, and is supervised by Dr.
Scott T. Gaynor, a licensed psychologist and faculty member in the WMU Psychology Department.
In the following paragraphs the treatment/research study will be described in detail. If after reading
and hearing about the study you are interested in participating you will begin the assessment process today.
The assessment process allows for collection of detailed information to determine if the treatment being
offered is a good fit for your child's needs. If after these assessment meetings you remain interested and
your child seems to be a good candidate for participation you will be enrolled in the treatment portion of the
study.
Assessment
The study treatment is aimed at helping children who are having a difficult time with sadness,
irritability, diminished interest or pleasure, sleeping problems, restlessness, fatigue, loss of energy,
diminished ability to think or concentrate, eating problems, and/or feelings of worthlessness. These are
considered to be symptoms of depression, but they can occur for a variety of reasons. Your child does not
have to be clinically depressed to participate, but does have to demonstrate some of the symptoms listed
above. This is because the treatment we are offering specifically targets these problems. Because the
treatment specifically targets these problems, if your child is not having many of these problems, or is
having substantial difficulties in other areas, or for other reasons, this treatment may not be best for him/her.
Therefore, the purpose of the assessment sessions is to more fully evaluate his/her functioning to determine
suitability for this study and its appropriateness for your child's needs.
The results of these detailed assessment meetings will ultimately determine whether this treatment
is a potential option for you and your child. If any of the assessment information indicates that this program
is not an option for your child, you will be informed as soon as this is known. In order to be included both
your child and you must speak and understand the English language sufficiently to complete the study
interviews and questionnaires. Because the intervention is verbal and will be conducted in English, it is
unlikely you will benefit if you cannot communicate in English. Additional reasons that might prevent your
child and you from participating would be if your child does not report struggling to a significant degree
with depressive symptoms, or if your child has psychological problems that require an alternative or
immediate treatment. Problems that would require an alternative or immediate treatment include engaging
in behaviors involving severe aggressive and unlawful actions, responses suggestive of bizarre perceptual
(hallucinatory) experiences or loss of contact with reality, or disabilities indicative of a severe pervasive
developmental disorder (such as autism or severe mental retardation). In addition, if your child is
determined to be currently at high risk for suicide, he/she will be excluded because of a need for immediate
intervention to maintain safety. If your child cannot participate in the study, you will be assisted in securing
the most appropriate care for your child. This assistance may range from provision of immediate crisis
management strategies and development of a safety plan to facilitating a referral to appropriate (crisis or
non-crisis) service providers. To further coordinate care, a summary of the information from the assessment
can be given to a mental health professional at your child's Vicksburg Community School (i.e., his/her
school counselor, psychologist, or social worker) if you consent to it and can be made available to other
subsequent care providers at your request. If after these assessment meetings this program appears to be a
good option for your child and you, you will be enrolled in the intervention (described below).
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Description of the Intervention
The intervention that will be offered is a treatment/research study. This treatment is called
cognitive behavioral therapy (CBT) and involves teaching you and your child new skills for changing
behavior, thinking, and interaction patterns in order to help improve his/her mood. CBT is the most studied
and evaluated talk therapy for children who present with depressive symptoms. In treatment studies such as
this one, CBT is delivered in a structured systematic fashion involving a set number of sessions and a
specific sequence of skills. While CBT has a promising track record of use with children and families, other
types of treatment are available. Psychological practitioners in the community often use family therapy
where all members of the household participate. In addition, some therapists use primarily supportive
therapy or implement CBT (or other) skills in a less structured fashion than we will do here. In addition,
some children with depressive symptoms are taken to see a child psychiatrist to determine if antidepressant
medication may be helpful for them. If an alternative approach is more appealing to you, we can help refer
you to these types of services.
The treatment is relatively brief (lasting about 2 months), but intensive. There will be 16 twiceweekly individual meetings (each lasting 45 minutes) between the therapist investigator and you child and
seven (60 minute) meetings with you and the therapist regarding your child (Portions of these meeting will
involve you, your child, and the therapist). While the treatment focuses on your child, as a caregiver you
will be actively involved in all the phases of the intervention - offering information, completing assessment
inventories, receiving summaries of the skills taught, helping your child use the skills learned at home, and
possibly making some changes in your behavior and relationship with your child. Thus, you recognize that
given your active role in the intervention, you too are a participant in this study.
The intervention is eight weeks long and is divided into two parts. The first part lasts four weeks
and is followed by a mid-treatment evaluation, after which the therapist investigator and you will discuss
you child's progress. The second part lasts four additional weeks and is followed by a post-treatment
evaluation, after which the therapist investigator and you will discuss your child's progress. In addition, you
will be contacted approximately 1 month after your termination date to complete a follow-up assessment. If
available, you may receive some modest financial compensation for attending the post-treatment and
follow-up sessions. In addition, the therapist investigator will briefly meet with your child's teacher at
pretreatment, mid-treatment, post-treatment, and 1-month follow-up. The meeting will be conducted in
order to discuss and collect data on the teacher's impressions of the child's depressive symptoms, peer
relationships and behavior. There is no charge for any of the assessments or intervention sessions offered as
a part of this project. Throughout the treatment study you will always be informed about the general
functioning of your child and about the general ideas covered in the sessions. However, therapy may be
more effective if a child does not fear that everything he/she discloses will be revealed to his/her caregiver
and therefore it is recommended that the specific details of what your child says during the assessment or
treatment sessions retain a level of confidentiality. However, you reserve the right to know everything that is
said during therapy and assessment sessions. Your child will not be informed of the details of the
information gathered from you. After each individual meeting the therapist will contact you via phone for a
5 minute therapist-caregiver conference to let you know what strategies were worked on in the individual
meeting. In addition, after the mid-treatment and post-treatment assessment meetings, the therapist
investigator will review your child's progress with you. Confidentiality is waived in cases of suicidality,
homicidality, child abuse or neglect, or urgent need for medical care, in which case the investigator will
take appropriate action, including informing you and contacting relevant authorities (i.e., Child and Family
Services) or emergency services as deemed necessary.
The intervention will begin as soon as possible following completion of the pretreatment
assessment. Depending on the number of children and families participating, it is possible that there may be
a delay until the therapist investigator is able to begin providing the intervention. The therapist
investigator's current availability can be discussed with you now to determine if this is likely to occur in
your case. Should there be a delay, your child will be monitored and receive services from one of the school
professionals (school counselor, school psychologist or social worker) in the interim.
Benefits and Risks
The primary direct benefit of your participation in the study is receiving a free assessment and
treatment. The assessment involves commonly used, standardized measures and the treatment, based on the
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most up-to-date information available on childhood depressive symptoms, is one that in prior studies
appears helpful and well received by children and families. The coping strategies that are the focus of the
treatment are ones that almost everyone could benefit from using. An indirect benefit from the participation
of you and your child is contributing to the scientific literature data relevant to determining how best to treat
children who present with depressive symptoms, which might improve the treatments offered to other
children.
Although no harmful consequences are anticipated for any participant (and it is our hope that all
participants will experience improvement) there are some potential risks requiring consideration. One risk
to you and your child of participating in this treatment is that you might experience some emotional
discomfort infillingout the questionnaires or answering questions during the clinical interviews. This risk is
common to any psychotherapy setting where disclosure of personal information to the therapist is required.
The information being gathered and the methods for gathering it have been used in clinical and research
settings and are not expected to generate undue stress, but do address sensitive issues. Also, sometimes,
even during treatment, depressive symptoms might worsen. The therapist investigator, because she will be
seeing your child twice weekly, will be able to detect any worsening symptoms and attempt to address them
as part of the treatment. However, should your child experience a dramatic worsening of symptoms during
treatment that necessitate another level of care, the therapist investigator will help you access such services.
As with any intervention, there is no way to be sure and we cannot guarantee improvement. It is possible
that the treatment will work well, but it is also possible that it will only help somewhat and possibly not at
all - what works well for some may not work for all people. If this treatment is not as helpful as you would
like, Ms. Eckshtain will discuss additional treatment options available at the conclusion of the intervention,
or if such additional treatment should be deemed necessary during the course of this intervention.
In addition, as in all research, there may be unforeseen risks. If any accidental injury occurs,
appropriate emergency measures will be taken; however no compensation or additional treatment will be
made available to you except as otherwise stated in this consent form. Finally, you are free to withdraw your
consent to participate at any time without penalty or prejudice and your decision to participate, or to
withdraw from participation at any time, has no bearing on any future relations with WMU or your ability to
receive other services from Vicksburg Community Schools. Should you discontinue your participation prior
to completion of the study you may be contacted and your child and you may be invited to participate in the
post-treatment and follow-up assessment sessions. There is no obligation to attend but, if available, you may
receive some modestfinancialcompensation for so doing.
The information obtained from your child and you during the study becomes the sole property of
WMU. As part of your participation, Ms. Eckshtain requests your permission to audio or video record part
or all of the assessment and treatment meetings. The audio or video tapes will be directly viewed only by
Dr. Gaynor or designated graduate students in the Ph.D. program in clinical psychology at WMU. The
purpose of the audio or video taping is to review and code Ms. Eckshtain's implementation of the
assessment and intervention sessions. After the review and coding of Ms. Eckshtain's implementation of the
sessions has occurred the audio/video tapes will be destroyed. To ensure confidentiality, the audio/video
tapes and the questionnaire or interview forms will be labeled only with a participant number. Your full
name and your child's full name will not appear on any of the questionnaires, interview forms, or
audio/video tape labels. The questionnaires, interview forms, or audio/video tapes will be stored in a locked
file cabinet, while the signed consent document and a master sheet containing the names of you and your
child and matching participant number will be stored in a separate locked file cabinet, both in the laboratory
of Dr. Gaynor at WMU. Only Ms. Eckshtain and Dr. Gaynor will have access to both the master sheet and
the data. The data sheets, containing only the participant number, will be viewed only by staff working on
this project and will be maintained for a period of at least five years after which they will be destroyed.
This research project and consent document have been approved for use for one year by the WMU
Human Subjects Institutional Review Board (HSIRB) as indicated by the stamped date and signature of the
board chair in the upper right corner. You should not participate in the study if the stamped date is older
than one year. Questions regarding the project and your rights can be answered by calling Dikla Eckshtain
at 269-387-4497, or by calling Dr. Gaynor at 269-387-4482. You may also contact the chair, Human
Subjects Institutional Review Board (269-387-8293) or the Vice President for Research (269-387-8298) if
questions or problems arise during the course of the study.
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Summary
Below is a summary of the material described above. To ensure that all matters have been fully
explained to you to your satisfaction and that your questions have been answered, you are being asked to
read each of the sentences below describing to what you are agreeing by signing this document. If and when
you feel these matters have been fully explained and your questions have been answered you should place
your initials and the date in the corresponding blank.
Your initials and signature below indicates that you have read the purpose and requirements of this
study entitled "Combined cognitive behavioral treatment plus caregiver sessions for childhood depression"
and agree to participate with your child, which involves:
Pre-treatment
1. 2 pre-treatment assessment sessions.
2. Allowing the investigators to exchange information with Vicksburg Community Schools.
Treatment
3. Your child attending 16 individual treatment sessions.
4. You attending 7 caregiver sessions. _ _ _ _ _ _ _ _
5. You and your child attending a mid-treatment assessment.
Post-treatment
6. Your child and you attending a post-treatment and 1 month follow-up assessment.
7. Allowing the investigators to contact you and invite you to attend the post-treatment and
follow-up assessment sessions even if your child and
you discontinue the treatment prior to its conclusion. _________
8. You are free to withdrawfromparticipation at any time without penalty or prejudice.

Caregiver Authorizing His/Her Participation (printed name & signature) Date
Legally Authorized Representative Authorizing Child's Participation
(printed name & signature)

Date

Child Participant

Date

Witness

Date
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Western Michigan University, Department of Psychology
Consent for Release of Information to School Professionals
Project Title: Combined cognitive behavioral treatment plus caregiver sessions for childhood depression.
Principal investigator: Scott. T. Gaynor, Ph.D

I

Co-Investigator: Dikla Eckshtain, M.A.

(parent/legally authorized guardian) hereby authorize: Ms. Eckshtain,

the therapist investigator, to provide Vicksburg Community Schools with a summary of the assessment
and/or treatment information regarding my child

.

Utilization of this form to release information is effective for the following period:
From

to

unless revoked by me in writing prior to the termination date.

My signature means that I have read this form and/or have had it read to me and explained in language that
I understand. I know what information is being disclosed.

Parent/Guardian signature:

Date:

Witness:

Date:
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Western Michigan University, Department of Psychology
Script/Assent to Allow Data to be Used for Research
Project Title: Combined cognitive behavioral treatment plus caregiver sessions for childhood depression
Principal investigator: Scott. T. Gaynor, Ph.D

Co-Investigator: Dikla Eckshtain, M.A.

As we just discussed with your (indicate parent/caregiver), we are doing a research study to try and figure
out the best ways to work with children. To do this we need to get information about how you are doing so
we can tell if what we work on with you helps. This information is called data. We would like to get data
from you by asking you to answer questions out loud and fill out some forms. Answering questions and
filling out forms as accurately and honestly as possible will help us figure out how you are doing and if this
treatment helps. Do you have any questions about this? [When questions have been answered] If you are
willing to participate in this way please write your name on the line below.

Child Participant (printed name & signature)

Date

Witness

Date
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TREATMENT PHASES
Week

Session

1-2

1
2

1

1
2
3
4
5
6
7
A
8
9
10
11
12

2
3
4
5
6
7

8

13
14
15

9

A
16

Pre-tx

1

1

2

2

3

4

A
4
5
6
A
7

5
7
9

A - Assessment

Session Type & # Emphasis/Skill
PRETREATMENT ASESSMENT
Consent form and caregiver assessment session
Caregiver& child
Assessment session
Child
INDIVIDUAL SESSIONS
Continue building rapport and introduction to treatment
Child
Child
Problem solving
Activity selection
Child
Child
Child
Learning to relax
Child
Presenting a positive self
Child
Child
Mid-treatment assessment
Child
Think positive. No negative thinking allowed
Child
Child
Think positive about myself
Child
Child
Some good things to do when bad things happen: Help from
a friend, Identify the Silver lining, No replaying bad
thoughts
Child
Combining primary and secondary control skills
Child
Using the ACT & THINK in my everyday life, sharing the
formulation and making the child more fluent in
Child
using the ACT & THINK chart and skills
Child
Post-treatment assessment
Child
Termination
CAREGIVER SESSIONS
Caregiver
Psychoeducation (after all assessment sessions and before 1st
individual child session)
Caregiver& child
Special time, praise, and positive communication (after 1st
individual child session)
Caregiver
Positive reinforcement of positive mood, positive mood
behaviors, and positive behaviors (after 3rd individual child
session)
Caregiver
Mid-treatment assessment
Caregiver
Review of mid-treatment assessment
Caregiver
Communication training (after 9th individual child session)
Caregiver& child
Family problem solving (after 11th individual child session)
Caregiver
Post-treatment assessment
Caregiver
Termination
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Western Michigan University, Department of Psychology
Explanation Script/Consent for the Teachers Regarding the Treatment Study
Project Title: Combined cognitive behavioral treatment plus caregiver sessions for childhood depression
My name is Dikla Eckshtain and I am an advanced graduate student pursuing my Ph.D. in Clinical
Psychology at Western Michigan University.
___ has enrolled in a treatment study entitled
"Combined cognitive behavioral treatment plus caregiver sessions for childhood depression" that I am
conducting with the support of Vicksburg Community Schools and under the supervision of Dr. Scott T.
Gaynor, a licensed psychologist and faculty member in the WMU Psychology Department.
The goal is to evaluate the effectiveness of cognitive behavioral therapy (CBT) provided in the school
setting. CBT involves teaching the caregiver and the child new skills for changing behavior, thinking, and
interaction patterns in order to help improve the child's mood and functioning. In treatment studies such as
this one, CBT is delivered in a structured systematic fashion involving a set number of sessions and a
specific sequence of skills. The treatment will last about 2 months and involves 16 twice-weekly 45-minute
individual meetings between me and the child and seven 60-minute meetings with the caregiver and the
child.
If possible, it would be helpful for us to receive information from the child's teacher about his/her social,
academic, behavioral and emotional abilities and difficulties. If you are willing to consider assisting in this
way, I would like to invite you to discuss your impressions of
and complete two brief
questionnaires regarding
that will take about 10 minutes to complete. I will ask you to
meet with me 4 times over the course of
's participation. These meeting will be brief and
if you are willing will occur prior to treatment (30 minutes), mid-treatment (10-15 minutes), post-treatment
(10-15 minutes), and 1-month follow-up (10 minutes). Do you have any questions?
Please sign below if you agree to meet with Ms. Dikla Eckshtain and provide the requested information.

Teacher printed name & signature

Date

Witness

Date
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45.25
16.01
33.19
10.86
9 mo.
28.08
7.15

47.40
8.04

25.07
7.09
1 mo.

24.14
7.97

7.06
6.12

6.00
7.94
9 mo.
5.77
5.15

18.63
5.32

17.73
7.09

1 mo.
5.93
8.78

16
9.40
44
75

PASCET

PASCET+
C-CRET
15
10.30
67
87

28.59
8.75

34.94
10.93
9 mo.

38.38
11.15

9 mo.
10.25
8.48

11.81
10.00

17.61
10.05

32
9.70
47
56

WLC

-

-

-

2 mo.
13.64
7.65

14.45
6.74

21.00
4.45

11
9.20
32
-

SCT

-

-

-

2 mo.
16.50
6.10

19.30
6.93

22.30
4.24

10
9.20
32
-

Attn

-

-

.

2 mo.
14.90
4.01

16.90
6.79

20.70
3.34

10
9.20
32
-

WLC

-

-

-

4 mo.
6.63
4.93

10.11
6.03

12.67
6.00

9
10.00
75
100

CBT

-

-

.

4 mo.
12.75
7.05

11.73
5.66

15.27
4.54

11
10.00
75
100

WLC

De Cuyper et al.
(2004)

20.69
3.45

22.91
4.36
2 mo.

37.22
8.36

2 mo.
5.36
5.04

8.04
6.65

21.60
5.48

9
11.20
44
-

Self-Con

24.28
4.68

24.16
6.01
2 mo.

33.50
10.27

2 mo.
7.34
7.23

9.04
8.32

22.40
8.47

10
11.01
40
-

BehPS

Stark etal. (1987)

22.60
5.03

28.15
6.21
2 mo.

30.33
6.28

2 mo.
7.40
5.68

18.60
9.91

20.11
9.88

9
11.32
44
-

WLC

Note. PASCET = Primary and Secondary Control Enhancement Training; C-CRET = Caregiver-Child Relationship Enhancement
Training; WLC = Waitlist Control; SCT = Social Competence Training; Attn = Attention Placebo Control; CBT = Cognitive Behavioral
Treatment; Self-Con = Self Control; Beh PS = Behavioral Problem Solving; Cauca = Caucasian; Pre = Pre Treatment; Post = Post
Treatment; FU = Follow Up; CDI = Children's Depression Inventory; CDRS-R = Children's Depression Rating Scale - Revised.

FUCDI
M
SD
Pre
CDRS-R
M
SD
Post
CDRS-R
M
SD
FU
CDRS-R
M
SD

Total n
Age
% female
% Cauca.
Pre CDI
M
SD
Post CDI
M
SD

variable

Eckshtain & Gaynor and Psychotherapy Studies Used for Benchmark
Eckshtain Weisz et al. (1997)
Liddle& Spence (1990)
& Gaynor
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38.40

10.50

8.04
25.07

58.50

73

46

12.20

48

Fluoxetine

47.40

87

67

10.30

15

PASCET+C-CRET

35.10

9.90

10.40
47.10

57.10

88.1

49.5

12.70

109

Fluoxetine

57.60

85

46

12.50

48

Placebo

40.20

11.80

55.10

76.4

49.1

12.69

109

Placebo

Emslie et al. (2002)

17.00
7.09
14.80
13.50
13.50
PASCET = Primary and secondary Control Enhancement Training; C-CRET = Caregiver-Child relationship Enhancement training; Pre = Pre Treatment; Post
= Post Treatment; CDRS-R = Child Depression Rating Scale - Revised.

Post CDRS-R
M
SD

Pre CDRS-R
M
SD

% Caucasian

% female

Age

Total n

Eckshtain <t
£: Gaynor ar
id Medication Studies Used for Benchmark
variable
Eckshtain & Gaynor
Emslie et al. (1997)
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Sessions Compared for Treatment Integrity

Parent

Child
Participant

Is'session
coded (1-5)

2nd session coded
(6-10)

Participant 1

5a

Participant 2

3

10

Participant 3

3

6

Participant 4

3

Participant 5

3rd sessicins
coded (11 -15)

Session coded
(2,3,5,6)

13
a

12

5

8

14

2

1

8a

11

6

Participant 6

2a

10

14

2

Participant 7

4a

6a

ir

5a

Participant 8

1

6

13

5

Participant 9

1

6

15

3

Participant 12

6b

9

13

3

Participant 13

2

8

14

6

Participant 14

1

10

13

3

Participant 15c

3

6

13

5

Additional participant

1

6

13

5a

Participant 10
Participant 11

Note. Additional participant refers to the participant whom data was taken out of statistical analyses,
"sessions coded by two coders. bSession 5 was chosen to be coded but was randomly changed to session
6 as it was not recorded. Participant that received treatment but data were not included in the analyses.
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ICHIGAN UNIVERSITY
Human Subjects Institutional Review Board

Date: October 7,2005
To:

Scott Gaynor, Principal Investigator
Dikla Eckshtain, Student Investigator for dissertation

From: Mary Lagerwey, Ph.D., Chair
Re:
HSIRB Project Number: 05-07-07
This letter will serve as confirmation that your research project entitled "Combined
Cognitive Behavior Treatment Plus Caregiver Sessions for Childhood Depression" has
been approved under the full category of review by the Human Subjects Institutional
Review Board. The conditions and duration of this approval are specified in the Policies
of Western Michigan University. You may now begin to implement the research as
described in the application.
Please note that you may only conduct this research exactly in the form it was approved.
You must seek specific board approval for any changes in this project. You must also
seek reapproval if the project extends beyond the termination date noted below. In
addition if there are any unanticipated adverse reactions or unanticipated events
associated with the conduct of this research, you should immediately suspend the project
and contact the Chair of the HSIRB for consultation.
The Board wishes you success in the pursuit of your research goals.

Approval Termination:

July 20, 2006

Walwood Hall, Kalamazoo, Ml 49008-5456
PHONE: (269) 387-8293 FAX; (269) 387-8276

